WO2016087879A1 - Formation of bonds by outer-sphere oxidative electrophilic fluorination - Google Patents

Formation of bonds by outer-sphere oxidative electrophilic fluorination Download PDF

Info

Publication number
WO2016087879A1
WO2016087879A1 PCT/GB2015/053732 GB2015053732W WO2016087879A1 WO 2016087879 A1 WO2016087879 A1 WO 2016087879A1 GB 2015053732 W GB2015053732 W GB 2015053732W WO 2016087879 A1 WO2016087879 A1 WO 2016087879A1
Authority
WO
WIPO (PCT)
Prior art keywords
nmr
metal
compound
mhz
formation
Prior art date
Application number
PCT/GB2015/053732
Other languages
French (fr)
Inventor
Dr John M. SLATTERY
Dr Jason M. LYNAM
Lucy M. MILNER
Lewis M. HALL
Original Assignee
University Of York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of York filed Critical University Of York
Publication of WO2016087879A1 publication Critical patent/WO2016087879A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B39/00Halogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds

Definitions

  • the present invention relates to a novel process for the fluorination of organic compounds.
  • the present invention relates to a novel process for the fluorination of organic compounds, such as alkynes, alkenes and arenes using an electrophilic fluorination agent.
  • Organofluorine chemistry plays a key role in materials science, pharmaceuticals, agrochemicals and medical imaging. However, the formation of new carbon-fluorine bonds with controlled regiochemistry and functional group tolerance is synthetically challenging.
  • Fluorine-containing organic molecules are found in a wide range of applications from liquid crystals to blockbuster drugs such as fluoxetine and atorvastatin, but are of particular interest in pharmaceuticals, agrochemicals and medical imaging.
  • the unique properties of C-F bonds which can improve metabolic stability, bioavailability and lipophilicity, mean that around 30 % of all agrochemicals and 20 % of all pharmaceuticals now contain fluorine.
  • the use of 18 F-labelled compounds in positron emission tomography (PET) is a highly active and important area of medical imaging research.
  • fluoride salts are often not ideal for the introduction of fluorine into organic molecules: in the presence of hydrogen-bonding solvents F " is a poor nucleophile and when anhydrous, although a better nucleophile, is it also highly basic and thus can result in unwanted side reactions.
  • Metal-mediated fluorination offers great potential to construct new fluorinated molecules, but even state-of-the-art approaches are limited in their substrate scope, often require activated substrates or do not allow access to desirable functionality, such as alkenyl C(sp 2 )-F or chiral C(sp 3 )-F centres.
  • the inventors have now developed a method for the formation of new aryl, alkenyl, alkyl and isonitrile C-F, C-CF 3 , C-SCF 3 and C-S0 2 CF 3 bonds in the coordination sphere of a metal, such as, ruthenium, via an unprecedented outer-sphere electrophilic fluorination (OSEF) mechanism.
  • the organometallic species involved are derived from non-activated substrates (for example, pyridine and terminal alkynes) and C-F bond formation occurs with full regio- and stereo- chemical control. Incorporation of this reactivity into stoichiometric or catalytic synthetic methodologies will significantly expand the range of fluorinated molecules available via metal-mediated fluorination.
  • the inventors have now developed a method for the formation of new aryl, alkenyl, alkyl and isonitrile C-F, C-CF 3 , C-SCF 3 and C-S0 2 CF 3 bonds in the coordination sphere of a metal, such as, ruthenium, via an unprecedented outer-sphere electrophilic fiuorination (OSEF) mechanism; provided that the electrophilic fiuorination does not proceed via formation of an intermediate metal-fluorine bond and where C-F, C-CF 3 , C-SCF 3 or C-S0 2 CF 3 bond formation is facilitated by metal-ligand back donation or formal metal oxidation from the M n to the M (n+2) oxidation state.
  • a metal such as, ruthenium
  • the present invention provides a novel method of fluorinating an organic compound using an electrophilic fluorinating agent.
  • a method of fiuorination of an alkenyl, alkynyl, aryl or isonitrile compound which comprises of reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer-sphere electrophilic fluorinating (OSEF) agent.
  • a metal-mediated outer-sphere electrophilic fluorinating (OSEF) agent e.g. the term "fluorination” shall include the introduction of one or more fluorine atoms to an organic or inorganic species, i.e. the formation of one or more C-F bonds; and/or the introduction of one or more trifluoromethyl (-CF 3 ) groups, i.e. the formation of C-CF 3 bonds.
  • a method which comprises the formation of one or more bonds selected from a C-F bond, a C-S-F bond and a C-S-CF 3 bond.
  • the "fluorination” comprises the introduction of a single fluorine atom, i.e. the formation of a single C-F bond; or the introduction of a single trifluoromethyl (-CF 3 ) group.
  • the method comprises the formation of a C-F bond.
  • the method comprises the formation of a C-CF 3 bond.
  • the method comprises the incorporation of multiple fluorine atoms by the formation of multiple C-F bonds.
  • the method comprises the incorporation of multiple trifluoromethyl (-CF 3 ) groups by the formation of multiple trifluoromethyl (C-CF 3 ) bonds.
  • the method comprises the formation of one or more C-S-F bonds.
  • S may also represent S0 2 .
  • the invention may comprise the formation of a single C-S-F bond or the formation of multiple C-S-F bonds.
  • the invention may comprise the formation of one or more C-S-CF 3 bonds.
  • S may represent S0 2 .
  • the invention may comprise the formation of a single C-S-CF 3 bond or the formation of multiple C-S-CF 3 bonds.
  • the metal should be a redox active metal such that C-F, C-CF 3 , C-S-F or C-S-CF 3 bond formation is facilitated by a metal that is capable of back donation or formal metal oxidation from the M n to the M (n+2) oxidation state, provided that the electrophilic fluorination does not proceed via formation of an intermediate metal- fluorine bond as hereinbefore described.
  • any metal capable of supporting ligands with the general features shown below is susceptible to electrophilic fluorination by the outer-sphere electrophilic fluorination method of the present invention.
  • [M] a metal fragment (as described above) and R, R' and R" are H, a carbon containing organic group, i.e. linear, branched or cyclic groups (including aromatic cyclic groups), or a heteroatom (such as N, O, S etc.) with associated functional groups.
  • the fluorination method of the present invention will generally comprise the use of a metal as hereinbefore described wherein the metal is in the form of a metal complex comprising one or more ligands bound to a metal centre.
  • the method of the invention will generally comprise direct outer-sphere electrophilic fluorination of a ligand bound to the metal centre.
  • Exemplary metals include, but shall not be limited to, iron or one or more Platinum Group Metals, i.e. transition metals in groups 8, 9 and 10.
  • Platinum Group Metals particularly comprise one or more of the metals iridium, osmium, palladium, platinum, rhodium and ruthenium.
  • the Platinum Group Metal is ruthenium.
  • Suitable ligands which may be used in the metal complex of the invention may comprise a "capping ligand", i.e. to a form "half- sandwich” metal complex, and one or more anionic or neutral ligands.
  • a suitable "capping ligand” is an aryl group or a tridentate ligand. Examples of aryl groups include, but shall not be limited to, C 5 H 5 , C 5 Me 5 , C63 ⁇ 4, C 7 H 7 and the like. Examples of tridentate ligands include, tris(pyrazolyl) (Tp), and the like.
  • Suitable anionic or neutral ligands include, but shall not be limited to, one or more of -CO, -CO2, phosphine, halide, pseudohalide, amine, -S(0)R 4 R 5 . If more than one anionic or neutral ligand is present, each of the anionic or neutral ligands may be the same or different.
  • halide as used herein shall include the term fluoride, chloride, bromide and iodide.
  • halide is chloride.
  • phosphine as used herein shall include, inter alia, -PH 3 and -PR P ⁇ R 3 , in which R 1 , R 2 and R 3 , which may be the same or different, are each alkyl C I to 20 or aryl or heteroatom- containing derivatives of these (e.g. pyridyl or imidazolyl). It may also include bi- and tri- dentate phosphine ligands as well as other multi-dentate analogues.
  • R 4 and R 5 which may be the same or different, are each hydrogen, alkyl CI to 20 or aryl or heteroatom-containing derivatives of these (e.g. pyridyl or imidazolyl).
  • the amount of the metal or metal complex may vary, depending upon the nature of the fluorinating agent, the organic compound, etc.
  • the amount of the metal or metal complex may be stoichiometric or catalytic.
  • the method of the invention will generally comprise an outer-sphere electrophilic fluorinating agent (OSEF) as hereinbefore described with a latent source of "F + " or "CF 3 + ".
  • OSEF outer-sphere electrophilic fluorinating agent
  • a latent source of "F + " will generally comprise an N-F fluorinating agent.
  • N-F fluorinating agents include, but shall not be limited to: N-fluorosulfon/w/des, such as N- fluorobenzenesulfonimide (NFSI) and N-fluoro-o-benzenedisulfonimide (NFOBS); N- fluoropyridinium salts, including N-fluoropyridinium tetrafluoroborate ([C 5 H 5 F][BF 4 ], from point onwards referred to as, [FPyr][BF 4 ]), tri-alkyl pyridinium tetrafluoroborates, such as, 1- fluoro-2,4,6-trimethylpyridinium tetrafluoroborate ([2,4,6-Me 3 C 5 H 2 F][BF 4 ], from this point onwards referred to as, [FTMP][BF ]), l-fluoro-2
  • the organic compound is a strongly nucleophilic substrate, such as, a metal alkynyl complex
  • the latent source of "F + " is other than N-fluoropyridinium tetrafluoroborate.
  • the fluorinating agent is a tri-alkyl pyridinium tetrafluoroborate, such as, l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate [2,4,6-Me 3 C 5 H 2 NF][BF 4 ] it is desirable that the pKa of the conjugate acid of the substrate is lower than the pKa of [2,4,6- Me 3 C 5 H 2 NF][BF 4 ] in the solvent system being used.
  • the counter-anion would generally be weakly-coordinating to the metal such as OTf, [BF 4 ] " ; [PF 6 ] " or others.
  • organic solvents include, but shall not be limited to CH 2 C1 2 or NCMe/CH 2 Cl 2 .
  • Suitable electrophilic trifluoromethylation reagents include, but shall not be limited to, 5- (trifluoromethyl)dibenzothiophenium tetrafluoroborate (from this point onwards referred to as, Umemoto's reagent), 5-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate and 3 ,3 -dimethyl- 1 -(trifluoromethyl)- 1 ,2-benziodoxole.
  • a preferred trifluoromethylation reagent is 5-(trifluoromethyl)dibenzothiophenium tetrafluoroborate.
  • the invention will allow the introduction of trifluoromethanesulfenyl "-SCF 3 ", and trifluoromethanesulfonyl "-S0 2 CF 3 " groups to an organic or inorganic species from an electrophilic source of these groups via an OSEF-type mechanism.
  • R, R', R" alkyl, aryl - as part of a
  • cyclic system may contain
  • Ligands at the metal defined elsewhere in the application will also be susceptible to this type of reactivity.
  • Electrophilic sources of "-SCF 3" include, but shall not be limited to: trifluoromethanesulfenylchloride, ⁇ -trifluoro ⁇ OS ⁇ trifluoromethyl) ester ethane(thioperoxoic) acid, 1, 1, 1 -trifluoro-N-methyl-N-phenyl-methanesulfenylamide, £/s(trifluoromethyl)disulfide, 1 , 3 -dihydro-3 , 3 -dimethyl- 1 - [(trifluoromethyl)thio] - 1,2- benziodoxole or 2-[(trifluoromethyl)thio]-lH-isoindole-l,3(2H)-dione.
  • Electrophilic sources of "-S0 2 CF 3 " include, but shall not be limited to:, l, l, l-trifluoro-, l, l'- anhydride, 1, 1, 1 -trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]-methanesulfonic acid, trifluoro-methanesulfonylchloride.
  • the method of the invention is suitable for the synthesis of a variety of fluorinated compounds.
  • the method is especially suitable for the synthesis of fluorinated vinylidene ligands.
  • vinylidene complexes are important intermediates in a range of metal catalysed reactions, access to fluorinated analogues will offer the potential for the formation of new fluorinated compounds.
  • the method of the invention is suitable for the introduction of fluorine into metal alkynyl (also called metal acetylide), metal alkenyl (metal vinyl) and related ligands systems, such as isonitriles.
  • metal alkynyl also called metal acetylide
  • metal alkenyl metal vinyl
  • related ligands systems such as isonitriles.
  • R is H, a carbon containing organic group, i.e. a linear branched or cyclic group, or a heteroatom (such as N, O, S etc.) with associated functional groups.
  • alkenyl may be tethered (via a functional group that is part of either R) to the metal wherein [M], R and X are the same as defined above, with the proviso that with the tether present we will need one fewer ligand than with a metal alkynyl.
  • EF is a source of fluoride and E is a cation, for example K + , Cs + , [ Et 4 ] + .
  • Fluoro (and trifluoromethyl) vinylidenes can be envisaged to act as intermediates in a range of transformations that their non-fluorinated analogues are implicated in, for example, the following (F can be substituted for -CF 3 in all cases). Where a chiral centre is formed during the reaction it should be possible by careful choice of ligand to produce an enantioselective process.
  • Substrates that will be susceptible to the related reactions of a vinyl complex include:
  • R, R' and R' ' would be understood by the person skilled in the art to comprise alkyl i.e. linear, branched or cyclic alkyl or aryl systems which themselves may contain heteroatoms and/or other functional groups.
  • the method of the invention is also applicable to other examples which rely on the formal oxidation of the metal centre to support a change in the bonding of an organic ligand.
  • examples which rely on the formal oxidation of the metal centre to support a change in the bonding of an organic ligand.
  • Illustrative reactions include:
  • a compound comprising a fluorinated alkenyl, aryl or isonitrile compound prepared by reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer-sphere electrophilic fluorinating agent (OSEF) according to any one of the preceding claims.
  • a fluorinated alkenyl, aryl or isonitrile compound prepared by reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer-sphere electrophilic fluorinating agent (OSEF) according to any one of the preceding claims.
  • a metal-mediated outer-sphere electrophilic fluorinating agent (OSEF)
  • the invention provides a compound as hereinbefore described which is a fluorinated alkenyl compound.
  • the invention provides a compound as hereinbefore described, which is a fluorinated aryl compound.
  • the invention provides a compound as hereinbefore described which is a fluorinated isonitrile compound.
  • vinylidene complexes are important intermediates in a range of metal catalysed reactions, access to fluorinated analogues offers the potential for the formation of new fluorinated compounds.
  • [2a][BF ] When the reaction between [la] and [FTMP][BF ] was performed in an NMR tube using CD 2 C1 2 solution, [2a][BF ], was found to be the sole phosphorus-containing product from the reaction.
  • the fluorine-carbon couplings confirm the incorporation of the halogen into the organic ligand. It should be noted that these resonances are shifted ca. 30 ppm and 70 ppm downfield respectively when compared to the hydrogen- substituted analogue [17a] + and that the metal bound carbon is observed at one of the lowest reported.
  • the vinylidene ligand shows a significant distortion from linearity (Ru(l)- C(6)-C(7) 164.20(15) °) whereas in the green isomer it is more typical for ruthenium vinylidene complexes (172.46(12) °).
  • the orientation of the phenyl substituent also changes between the two isomeric forms, notably in the green crystals the ring lies perpendicular to the plane of the vinylidene.
  • Another illustrative example is the formation, and subsequent fluorination, of the ruthenium vinyl pyridylidene ([20][PF 6 ]) and 1-ruthanaindolizine complexes [9] which are prepared by reaction of [Ru ⁇ 5 -C 5 H 5 )(PPh 3 )(Pyr) 2 ][PF 6 ], [19][PF 6 ] with terminal alkynes.
  • HRESIMS showed the presence of a cationic molecular ion at 696.1023 m/z, which is consistent with mono-fluorination of [9].
  • the spectroscopic data are not consistent with oxidative fluorination of the metal to form a Ru-F which would be expected to exhibit a significantly upfield 19 F chemical shift of around ⁇ -250 ppm.
  • Ru can be considered to have a formal oxidation state of +4 (with one Fischer-type and one Schrock- type carbene ligand present).
  • the electrophilic fluorination reaction is distinctly different from other previously reported metal-mediated electrophilic fluorination reactions. 1 It is oxidative (with regard to the metal), which is similar to related Pd chemistry, 1 but different to non-redox electrophilic fluorination reactions promoted by Lewis acidic metals (e.g. Ti). 1 However, unlike in the Pd cases the reaction produces an outer-sphere fluorination product, which we believe occurs without the involvement of a Ru-F intermediate.
  • [10][BF 4 ] is enantiopure, containing only the RR enantiomer.
  • This diastereoselectivity is driven by sterics: "F + " addition to the "inside” face of the 1-ruthanaindolizine ring is blocked by the three Ph groups on the phosphine.
  • This is likely to be a kinetic, rather than thermodynamic, effect as the products of "F + " addition to the two faces are found to be essentially isoenergetic (-194 and -192 kJ mol "1 for the "outside” and “inside” faces respectively, relative to [9] and [FTMP] + ) in DFT studies ⁇ vide infra).
  • [10][BF 4 ] is susceptible to further electrophilic fluorination.
  • [FTMP][BF 4 ] are added to [9] in dichloromethane, [10][BF 4 ] is observed to form immediately in the NMR spectra and over a period of 24 h this species converts cleanly to a new complex [21][BF 4 ].
  • C-F bond lengths C(l l)-FQ) ( 1.374(3) A ⁇ and C(l l)-F(2) ( 1.353(3) A ⁇ in [21][BF 4 ]are significantly shorter than in [10][BF 4 ] and are more similar to typical sp 3 C-F bond lengths, with slightly less distortion around C(l 1) from ideal tetrahedral angles.
  • the metallocycle [22] can also be formed independently by deprotonation of [10][BF ] with l,4-diazabicyclo[2.2.2]octane (DABCO) in CH 2 C1 2 .
  • [10] + shows features that suggest that a Ru-F complex is not an intermediate in the formation of [10] + .
  • [10] + is not the thermodynamic product of "F + " migration from either Ru-F isomer to a carbon atom on the metallocycle.
  • the thermodynamic product is [29Z] + , which is not observed experimentally, where the 2-position of the ruthanindolizine is fluorinated.
  • [29Z] + is also the kinetic product of "F + " migration, being formed via a transition state that lies 130 kJ mol "1 higher in energy than the Ru-F complex [27b] + .
  • the calculations suggest that there is a very significant barrier (+204 kJ mol "1 ) to formation of the observed product [10] + from
  • the open-shell pathways are found be lower in energy than the closed-shell pathway, which suggests that a SET mechanism may operate in this system (although care should be taken in interpreting the energies of the singlet diradical states, due to spin contamination).
  • the low barriers to fluorination directly at the ligand contrasts markedly with the large barriers for C-F bond formation via a metal-fluoride intermediate, supporting the proposal that the reaction proceeds by an outer-sphere mechanism.
  • Figure 1 illustrates the solid state structures of the [2a] + cation found in (a) green crystals and (b) orange crystals. Hydrogen atoms removed for clarity and thermal ellipsoids (where shown) are at the 50 % probability level;
  • Figure 2 illustrates the UV- visible spectra of the two isomers of complex [2][PF 6 ] recorded (a) in the solid state with the diffuse reflectance technique and (b) in CH 2 CI 2 solution;
  • Figure 3 illustrates the variable temperature 19 F NMR spectra of [10][BF 4 ] and DABCO (CF 3 region);
  • Figure 4 illustrates the variable temperature 19 F NMR spectra of [10][BF 4 ] and DABCO
  • Figure 5 illustrates the variable temperature 19 F NMR spectra of [10][BF 4 ] and DABCO (BF 4 region);
  • Figure 6 illustrates the variable temperature 31 P NMR spectra of [10][BF 4 ] and DABCO;
  • Figure 7 illustrates the solid state structure of the cation [12] + , hydrogen atoms omitted for clarity, thermal ellipsoids (where shown) are at the 50 % probability level;
  • Figure 8 illustrates the solid state structure of the cation [10] + , most hydrogen atoms omitted for clarity, thermal ellipsoids (where shown) at the 50 % probability level;
  • Figure 9 illustrates the solid state structure of the cation [21] + , hydrogen atoms omitted for clarity, thermal ellipsoids (where shown) are at the 50 % probability level;
  • Figures 10(a) to (b) illustrate absorption spectra for certain specified complexes
  • Figures 11(a) to (d) illustrate solid state structures for certain specified complexes.
  • NMR spectra were acquired on a Jeol ECX-400 (Operating frequencies 1H 399.78 MHz, 31 P 161.83 MHz, 19 F 376.17 MHz, 13 C 100.53 MHz), a Bruker AVANCE 500 (Operating frequencies 1H 500.13 MHz, 31 P 202.47 MHz, 19 F 470.69 MHz, 13 C 125.77 MHz) or a Bruker AVANCE 700 (Operating frequencies 1H 700.13 MHz, 31 P 283.46 MHz, 13 C 176.07 MHz). 31 P and 13 C spectra were recorded with proton decoupling. Assignments were confirmed with the aid of 2D-COSY, NOESY, HMQC and HMBC experiments. Mass spectra were recorded on a Bruker micrOTOF using electrospray ionisation.
  • Example 49 Example 49
  • Diffraction data was collected using an Oxford Diffraction SuperNova diffractometer equipped with a single Molybdenum source using Mo-K a radiation (0,71073 A) and an EOS CCD camera. The crystals were cooled with an Oxford Instruments Cryojet typically to 11 OK. Diffractometer control, data collection, initial unit cell determination, frame integration and unit-cell refinement was carried out with "CrysalisPro”. Face-indexed absorption corrections were applied either using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm or analytical numeric absorption correction using a multifaceted crystal model based on expressions derived by Clark and Reid, implemented within "CrysalisPro".
  • OLEX2 was used for overall structure solution, refinement and preparation of computer graphics and publication data. Using 01ex2, the structure was solved either with the Superflip structure solution program using Charge Flipping or the ShelXS structure solution program using Direct Methods. Refinement was carried out with the ShelXL refinement package using Least Squares minimisation. All non-hydrogen atoms were refined anisotropically. Unless stated otherwise, hydrogen atoms were placed using a "riding model" and included in the refinement at calculated positions.
  • the dichloromethane of crystallization has a disordered chloride atom, which has been modelled in two positions with a refined occupancy ratio of 0.77:0.23(3).
  • the PF 6 counter-ion was disordered (rotation about one F-P-F axis), and four fluorine atoms were modelled in two positions with occupancies of 0.957:0.043(3).
  • the fluorine atoms of the minor component were restrained to be approximately isotropic and the distances between them were restrained to be equal.
  • the ADP of opposite pairs of fluorine atoms in the minor component were constrained to be equivalent e.g. F4A and F6A.
  • the tetrafluoroborate anion was disordered, with three of the fluorines each modelled in two positions with refined occupancies of 0.903 :0,097(4).
  • the dichloromethane of crystallisation was also disordered with one of the chlorines modelled in two positions with refined occupancies of 0.663 : 0.337(3 ) .
  • [Ru( 5 -C 5 H 5 )(PPh 3 ) 2 (-C(NC 5 H 5 ) C(C 6 H 5 )F)] [BF 4 ], [15] [BF 4 ].
  • the BF4 was disordered and modelled in two positions. The occupancies were refined to 0.65:0.35 (4). The boron-fluorine bond lengths were restrained to 1.4 A and the fluorine- fluorine bond lengths were restrained to 2.285 A. Rii(i
  • 5 ⁇ C 5 H s )(PPh 3 ) 2 (-C 5 H 4 N ⁇ C ⁇ NC 5 H 5 ) C(C 6 H 5 ) ⁇ )] [BF 4 ], [16] [BF 4 ].
  • the structure was non-merohedrally twinned and modelled using 2-components.
  • the asymmetric unit contained two complex cations, two tetrafluoroborate anions and a pyridine of crystallisation.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

There is described a method of fluorination of an alkenyl, alkynyl, aryl or isonitrile compound which comprises reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer-sphere electrophilic fluorinating (OSEF) agent.

Description

Formation of Bonds by Outer-Sphere Oxidative Electrophilic Fluorination
Field of the Invention
The present invention relates to a novel process for the fluorination of organic compounds.
More particularly, the present invention relates to a novel process for the fluorination of organic compounds, such as alkynes, alkenes and arenes using an electrophilic fluorination agent.
Background to the Invention
Organofluorine chemistry plays a key role in materials science, pharmaceuticals, agrochemicals and medical imaging. However, the formation of new carbon-fluorine bonds with controlled regiochemistry and functional group tolerance is synthetically challenging.
Fluorine-containing organic molecules are found in a wide range of applications from liquid crystals to blockbuster drugs such as fluoxetine and atorvastatin, but are of particular interest in pharmaceuticals, agrochemicals and medical imaging. The unique properties of C-F bonds, which can improve metabolic stability, bioavailability and lipophilicity, mean that around 30 % of all agrochemicals and 20 % of all pharmaceuticals now contain fluorine. In addition, the use of 18F-labelled compounds in positron emission tomography (PET) is a highly active and important area of medical imaging research.
As such, there is a synthetic requirement to develop simple, efficient (and in the case of 18F labelling, where the 18F half life is short, rapid) methods for the introduction of fluorine into organic molecules. Selective formation of new carbon-fluorine bonds, particularly in the presence of sensitive functional groups, is synthetically challenging.1 There has been a focus in recent years on the development of new transition-metal-mediated C-F bond forming reactions, which offer significant potential for regioselectivity and atom- and step-economy under mild conditions. There have recently been some significant advances in metal-catalysed fluorination using fluoride salts as the fluorine source.1"11
However, fluoride salts are often not ideal for the introduction of fluorine into organic molecules: in the presence of hydrogen-bonding solvents F" is a poor nucleophile and when anhydrous, although a better nucleophile, is it also highly basic and thus can result in unwanted side reactions.
To circumvent these problems, a number of metal-catalysed electrophilic fluorination reactions have been developed, where C-F bonds are formed from latent sources of "F"1"".1' 12" 17 In the majority of these cases there is an initial metal-fluoride bond formation with concomitant oxidation of the metal, which then induces C-F reductive elimination or oxidises the substrate to form a radical that subsequently abstracts F' from the metal. These are powerful strategies that are broadly applicable, but there are some limitations. Directing groups and/or pre-activation of the substrates (for example by formation of an aryl stannane, silane or boronic acid) are generally required to promote the reactions.18"23 In addition, these systems have typically focussed on aryl C-F bond formation. As such, the development of new regio- and stereo- specific metal-mediated electrophilic fluorination reactions, without the need for directing and activating groups, is of great interest. Reactions that allow the construction of less common structural frameworks, for example those containing alkenyl or alkyl C-F bonds (especially chiral C(sp3)-F centres) are particularly interesting. Although examples of Lewis acidic metal-mediated C(sp3)-F bond formation have been reported,1 these reactions often require highly activated substrates, typically those which form stabilised carbanions (e.g. β-diketones), which reduces potential substrate scope.
The development of new classes of metal-catalysed reactions is frequently informed by the observation of unusual stoichiometric organometallic reactivity and a comprehensive understanding of the key mechanistic steps involved in a given reaction, an example being the development of alkene metathesis catalysts.
Metal-mediated fluorination offers great potential to construct new fluorinated molecules, but even state-of-the-art approaches are limited in their substrate scope, often require activated substrates or do not allow access to desirable functionality, such as alkenyl C(sp2)-F or chiral C(sp3)-F centres.
The inventors have now developed a method for the formation of new aryl, alkenyl, alkyl and isonitrile C-F, C-CF3 , C-SCF3 and C-S02CF3 bonds in the coordination sphere of a metal, such as, ruthenium, via an unprecedented outer-sphere electrophilic fluorination (OSEF) mechanism. The organometallic species involved are derived from non-activated substrates (for example, pyridine and terminal alkynes) and C-F bond formation occurs with full regio- and stereo- chemical control. Incorporation of this reactivity into stoichiometric or catalytic synthetic methodologies will significantly expand the range of fluorinated molecules available via metal-mediated fluorination. There are no examples of reactions in which it has been possible to use a source of F+ to incorporate fluorine directly (not via metal-fluorine bond formation) into an organic ligand bound to a redox-active transition metal, where C-F bond formation is facilitated by metal- ligand back donation or formal metal oxidation from the Mn to the M(n+2) oxidation state. Such a process is of particular interest given that metal complexes may significantly alter the reactivity of coordinated ligands and, as such, offer new methods for both initial C-F bond formation and subsequent functionalisation.
Summary to the Invention
The inventors have now developed a method for the formation of new aryl, alkenyl, alkyl and isonitrile C-F, C-CF3 , C-SCF3 and C-S02CF3 bonds in the coordination sphere of a metal, such as, ruthenium, via an unprecedented outer-sphere electrophilic fiuorination (OSEF) mechanism; provided that the electrophilic fiuorination does not proceed via formation of an intermediate metal-fluorine bond and where C-F, C-CF3, C-SCF3 or C-S02CF3 bond formation is facilitated by metal-ligand back donation or formal metal oxidation from the Mn to the M(n+2) oxidation state.
The present invention provides a novel method of fluorinating an organic compound using an electrophilic fluorinating agent.
Thus, according to a first aspect of the invention there is provided a method of fiuorination of an alkenyl, alkynyl, aryl or isonitrile compound which comprises of reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer-sphere electrophilic fluorinating (OSEF) agent. For the avoidance of doubt, the term "fluorination" shall include the introduction of one or more fluorine atoms to an organic or inorganic species, i.e. the formation of one or more C-F bonds; and/or the introduction of one or more trifluoromethyl (-CF3) groups, i.e. the formation of C-CF3 bonds.
In one embodiment of the invention there is provided a method which comprises the formation of one or more bonds selected from a C-F bond, a C-S-F bond and a C-S-CF3 bond.
In a particular embodiment the "fluorination" comprises the introduction of a single fluorine atom, i.e. the formation of a single C-F bond; or the introduction of a single trifluoromethyl (-CF3) group. Thus, in one aspect of the invention the method comprises the formation of a C-F bond. In another aspect of the invention the method comprises the formation of a C-CF3 bond. In another aspect of the invention the method comprises the incorporation of multiple fluorine atoms by the formation of multiple C-F bonds. In another aspect of the invention the method comprises the incorporation of multiple trifluoromethyl (-CF3) groups by the formation of multiple trifluoromethyl (C-CF3) bonds.
In another aspect of the invention the method comprises the formation of one or more C-S-F bonds. For the avoidance of doubt, in the formation of one or more C-S-F bonds, S may also represent S02. Thus, the invention may comprise the formation of a single C-S-F bond or the formation of multiple C-S-F bonds. The invention may comprise the formation of one or more C-S-CF3 bonds. Similarly, S may represent S02. The invention may comprise the formation of a single C-S-CF3 bond or the formation of multiple C-S-CF3 bonds. In the metal-mediated method of the invention the metal should be a redox active metal such that C-F, C-CF3, C-S-F or C-S-CF3 bond formation is facilitated by a metal that is capable of back donation or formal metal oxidation from the Mn to the M(n+2) oxidation state, provided that the electrophilic fluorination does not proceed via formation of an intermediate metal- fluorine bond as hereinbefore described.
In general, any metal capable of supporting ligands with the general features shown below (either as isolated species, or as intermediates in a stoichiometric or catalytic transformation) is susceptible to electrophilic fluorination by the outer-sphere electrophilic fluorination method of the present invention.
As part of a cyclic
system or not, may
contain elements other
than carbon or not,
cyclic system may be
aromatic or not
Figure imgf000007_0001
Metal vinyl species
(and their derivatives)
Where [M] = a metal fragment (as described above) and R, R' and R" are H, a carbon containing organic group, i.e. linear, branched or cyclic groups (including aromatic cyclic groups), or a heteroatom (such as N, O, S etc.) with associated functional groups.
Thus, the fluorination method of the present invention will generally comprise the use of a metal as hereinbefore described wherein the metal is in the form of a metal complex comprising one or more ligands bound to a metal centre. The method of the invention will generally comprise direct outer-sphere electrophilic fluorination of a ligand bound to the metal centre.
Exemplary metals include, but shall not be limited to, iron or one or more Platinum Group Metals, i.e. transition metals in groups 8, 9 and 10. Platinum Group Metals particularly comprise one or more of the metals iridium, osmium, palladium, platinum, rhodium and ruthenium. In an especially preferred aspect of the invention the Platinum Group Metal, is ruthenium.
Suitable ligands which may be used in the metal complex of the invention may comprise a "capping ligand", i.e. to a form "half- sandwich" metal complex, and one or more anionic or neutral ligands. When the metal complex comprises one or more anionic ligands, they are preferably mono-anionic. A suitable "capping ligand" is an aryl group or a tridentate ligand. Examples of aryl groups include, but shall not be limited to, C5H5, C5Me5, C6¾, C7H7 and the like. Examples of tridentate ligands include, tris(pyrazolyl) (Tp), and the like. Suitable anionic or neutral ligands include, but shall not be limited to, one or more of -CO, -CO2, phosphine, halide, pseudohalide, amine, -S(0)R4R5. If more than one anionic or neutral ligand is present, each of the anionic or neutral ligands may be the same or different.
The term halide as used herein shall include the term fluoride, chloride, bromide and iodide. Preferably the term halide is chloride.
The term phosphine as used herein shall include, inter alia, -PH3 and -PR P^R3, in which R1, R2 and R3, which may be the same or different, are each alkyl C I to 20 or aryl or heteroatom- containing derivatives of these (e.g. pyridyl or imidazolyl). It may also include bi- and tri- dentate phosphine ligands as well as other multi-dentate analogues.
R4 and R5, which may be the same or different, are each hydrogen, alkyl CI to 20 or aryl or heteroatom-containing derivatives of these (e.g. pyridyl or imidazolyl).
The amount of the metal or metal complex may vary, depending upon the nature of the fluorinating agent, the organic compound, etc. The amount of the metal or metal complex may be stoichiometric or catalytic.
The method of the invention will generally comprise an outer-sphere electrophilic fluorinating agent (OSEF) as hereinbefore described with a latent source of "F+" or "CF3 +".
A latent source of "F+" will generally comprise an N-F fluorinating agent. Such N-F fluorinating agents include, but shall not be limited to: N-fluorosulfon/w/des, such as N- fluorobenzenesulfonimide (NFSI) and N-fluoro-o-benzenedisulfonimide (NFOBS); N- fluoropyridinium salts, including N-fluoropyridinium tetrafluoroborate ([C5H5 F][BF4], from point onwards referred to as, [FPyr][BF4]), tri-alkyl pyridinium tetrafluoroborates, such as, 1- fluoro-2,4,6-trimethylpyridinium tetrafluoroborate ([2,4,6-Me3C5H2 F][BF4], from this point onwards referred to as, [FTMP][BF ]), l-fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate, 2,6-dichloro-l -fluoropyridinium trifluoromethanesulfonate or 1- fluoro 2,6-dichloropyridinium tetrafluoroborate; l,4-diazabicyclo[2.2.2]octane (DABCO) bis(ammonium) ions, such as l-chloromethyl-4-fluoro-l,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate (Selectfluor®); and N-fluoro-N'-(chloromethyl)triethylenediamine bis(tetrafluoroborate) and the like. Illustrative N-F fluorinating agents include:
Figure imgf000010_0001
N-fluoropyridinium salts
When the organic compound is a strongly nucleophilic substrate, such as, a metal alkynyl complex, then it is preferred that the latent source of "F+" is other than N-fluoropyridinium tetrafluoroborate.
More specifically, if the fluorinating agent is a tri-alkyl pyridinium tetrafluoroborate, such as, l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate [2,4,6-Me3C5H2NF][BF4] it is desirable that the pKa of the conjugate acid of the substrate is lower than the pKa of [2,4,6- Me3C5H2NF][BF4] in the solvent system being used. The counter-anion would generally be weakly-coordinating to the metal such as OTf, [BF4]" ; [PF6]" or others.
It would be understood by the person skilled in the art that a range of organic solvents may suitably be used in the method of the present invention. Exemplary solvents include, but shall not be limited to CH2C12 or NCMe/CH2Cl2.
Suitable electrophilic trifluoromethylation reagents include, but shall not be limited to, 5- (trifluoromethyl)dibenzothiophenium tetrafluoroborate (from this point onwards referred to as, Umemoto's reagent), 5-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate and 3 ,3 -dimethyl- 1 -(trifluoromethyl)- 1 ,2-benziodoxole. A preferred trifluoromethylation reagent is 5-(trifluoromethyl)dibenzothiophenium tetrafluoroborate.
Figure imgf000011_0001
5-(trifluoromethyl)dibenzothiophenium tetrafluoroborate (Umemoto's reagent)
In addition to the formation of one or more C-F bonds and/or the introduction of one or more trifluoromethyl (-CF3) groups, the invention will allow the introduction of trifluoromethanesulfenyl "-SCF3", and trifluoromethanesulfonyl "-S02CF3" groups to an organic or inorganic species from an electrophilic source of these groups via an OSEF-type mechanism.
Figure imgf000011_0002
Θ
[M]- -R [M]=C
E = SCF3, S02CF3
E' = CH, N, O, S etc
R, R', R" = alkyl, aryl - as part of a
cyclic system, or not, may contain
elements other than carbon, or
not; may be aromatic, or not etc The metal species defined elsewhere in the application will also be susceptible to this type of reactivity and the formation of new C-SCF3 and C-SO2CF3 bonds will occur in a similar way to C-F and C-CF3 bond formation.
Ligands at the metal defined elsewhere in the application will also be susceptible to this type of reactivity.
Electrophilic sources of "-SCF3" include, but shall not be limited to: trifluoromethanesulfenylchloride, ^ -trifluoro^OS^trifluoromethyl) ester ethane(thioperoxoic) acid, 1, 1, 1 -trifluoro-N-methyl-N-phenyl-methanesulfenylamide, £/s(trifluoromethyl)disulfide, 1 , 3 -dihydro-3 , 3 -dimethyl- 1 - [(trifluoromethyl)thio] - 1,2- benziodoxole or 2-[(trifluoromethyl)thio]-lH-isoindole-l,3(2H)-dione.
Electrophilic sources of "-S02CF3" include, but shall not be limited to:, l, l, l-trifluoro-, l, l'- anhydride, 1, 1, 1 -trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]-methanesulfonic acid, trifluoro-methanesulfonylchloride.
Electrophilic Sources of "SCF3"
F3C
Figure imgf000012_0001
The method of the invention is suitable for the synthesis of a variety of fluorinated compounds. However, the method is especially suitable for the synthesis of fluorinated vinylidene ligands. As vinylidene complexes are important intermediates in a range of metal catalysed reactions, access to fluorinated analogues will offer the potential for the formation of new fluorinated compounds.
The method of the invention is suitable for the introduction of fluorine into metal alkynyl (also called metal acetylide), metal alkenyl (metal vinyl) and related ligands systems, such as isonitriles.
A general example of the process of fluorinating a metal alkynyl is:
Figure imgf000013_0001
Where [M] is a metal-based fragment, such as (but not limited to), [M^XI^XL2)] (M = Mn, Re, Fe, Ru, Os, Rh, Ir); L is a facially capping ligand such as C5H5, C5Me5, 06Η6, C7H7, Tp, etc., L1 = CO, phosphine, halide, etc. L2 = same ligand set as L1 may be the same or different in each case, L1 and L2 could also be part of the same bidentate ligand e.g. dppe (Ph2PC2H4PPh2)) - i.e. the full range of "half-sandwich metal alkynyl complexes"; and R, is H, a carbon containing organic group, i.e. a linear branched or cyclic group, or a heteroatom (such as N, O, S etc.) with associated functional groups. Octahedral complexes [MX(P)4], [MX(CO)(P)2] or [MX2P2]" (M = Fe, Ru, Os, X = halide, carboxylate, P = phosphine ligand) and square planar [MX(P)2] (M = Rh, Ir, X = halide, P = phosphine ligand) are included. More specific examples are:
Figure imgf000014_0001
[1 b] R = C6H4-4-CF3 [2b][BF4] R = C6H4-4-CF3 [1 c] R = C6H4-4-OMe [2c][BF4] R = C6H4-4-OMe [1 d] R = fBu [2d][NSI] R = 'Bu*
Figure imgf000014_0002
[1 adppe] [2adppe][NSI]
Figure imgf000014_0003
[3adppe] R - H [4adppe][NSI] R = H [3bdppe] R = F [4bdppe][NSI] R = F
Figure imgf000014_0004
' NFSI, Toluene, 0 °C, 45 min A general example of the process of fluorinating a metal alkenyl is:
Figure imgf000015_0001
in which the alkenyl may be tethered (via a functional group that is part of either R) to the metal wherein [M], R and X are the same as defined above, with the proviso that with the tether present we will need one fewer ligand than with a metal alkynyl.
A further general example of the process of alkene C-H fluorination and trifluoromethylation is:
[M] stoichiometric/catalytic
+ "F+" or "CF3 + + [H. base]+
Where R contains a
Figure imgf000015_0002
directing group that can
bind to the metal (or not) wherein [M], R and R' are the same as defined above.
These two processes may be combined in the presence of a suitable nucleophile and an excess of electrophilic fluorinating agent to permit the incorporation of multiple fluorine atoms in the substrate. An example is:
Figure imgf000016_0001
wherein [M], R and R' are the same as defined above, EF is a source of fluoride and E is a cation, for example K+, Cs+, [ Et4]+.
A specific example being:
Figure imgf000016_0002
Fluoro (and trifluoromethyl) vinylidenes can be envisaged to act as intermediates in a range of transformations that their non-fluorinated analogues are implicated in, for example, the following (F can be substituted for -CF3 in all cases). Where a chiral centre is formed during the reaction it should be possible by careful choice of ligand to produce an enantioselective process.
a nti- Markovnikov
carboxylic acid addition
Figure imgf000017_0001
H formation
Nuc'
Specific examples in which the reactivity has been demonstrated include:
Ph
Figure imgf000018_0001
[2a][BF4] [7] [8Ph]
Figure imgf000018_0002
[4adppe][NSI] [18*dppe][NSI] [8H]
This reactivity with fluoride and pyridine is also observed with the analogous fluorovinylidene complex with dppe - [Ru^5-C5H5)(dppe)(=C=CPhF)][NSI], [2edpPe][NSI] - and with an [NSI]" counter-ion in place of the [BF4]" illustrated above. The formation of [8Ph] occurs via a-fluorophenylacetaldehyde, [8Ph'] as described in the experimental section. The formation of [8H] presumably occurs via a-fluoro acetaldehyde [8Η'] as similarly observed with [8Ph].
Substrates that will be susceptible to the related reactions of a vinyl complex include:
Figure imgf000019_0001
in which R, R' and R' ' would be understood by the person skilled in the art to comprise alkyl i.e. linear, branched or cyclic alkyl or aryl systems which themselves may contain heteroatoms and/or other functional groups.
A more specific example is:
Figure imgf000019_0002
A proposed general mechanism for this type of reaction is shown below (where X is a functional group capable of binding to the metal, R is an alkyl or aryl group, including alkyl or aryl groups containing additional functional groups and/or heteroatoms):
Figure imgf000019_0003
Furthermore, the direct fluorination of heterocyclic systems is envisaged, including transformations such as:
Figure imgf000020_0001
The method of the invention is also applicable to other examples which rely on the formal oxidation of the metal centre to support a change in the bonding of an organic ligand. For example:
Figure imgf000020_0002
Illustrative reactions include:
Figure imgf000021_0001
[1b] R = C6H4-4-CF3 [2b][BF4] R = C6H4-4-CF3
[1c] R = C6H4-4-OMe [2c][BF4] R = C6H4-4-OMe
[1d] R = 'Bu [2d][NSI] R = ¾u*
Figure imgf000021_0002
[1 adppe] [2adppe][NSI]
Figure imgf000021_0003
[1a] R= Ph [11a][BF4] R
[1 b] R = C6H4-4-CF3 11b BF4] R
Figure imgf000021_0004
[1a] R = Ph
(does not react with py)
Figure imgf000021_0005
* NFSI, Toluene, 0 °C, 45 min
Figure imgf000022_0001
[14][BF4] R = P
Figure imgf000022_0002
DCM, rt,
1 week,
-HF
Figure imgf000022_0003
[16][BF4]
According to a further aspect of the invention there is provided a compound comprising a fluorinated alkenyl, aryl or isonitrile compound prepared by reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer-sphere electrophilic fluorinating agent (OSEF) according to any one of the preceding claims.
Thus, in one aspect the invention provides a compound as hereinbefore described which is a fluorinated alkenyl compound. In another aspect the invention provides a compound as hereinbefore described, which is a fluorinated aryl compound. In yet another aspect the invention provides a compound as hereinbefore described which is a fluorinated isonitrile compound. A further illustrative example is the use of the ruthenium complex [Ru( 5-C5H5X- C≡CPh)(PPh3)2], [la], as it has shown that reaction of this species with electrophiles H+,24 Cl2, Br2, 12,25 leads to stable vinylidene complexes [Ru^5-C5H5)(=C=C{E}Ph)(PPh3)2]+ (E = H, CI, Br, I). As vinylidene complexes are important intermediates in a range of metal catalysed reactions, access to fluorinated analogues offers the potential for the formation of new fluorinated compounds.
Treatment of a CH2C12 solution of [Ru^5-C5H5)(-C≡CPh)(PPh3)2], [la], with l-fluoro-2,4,6- trimethylpyridinium tetrafluoroborate [FTMP][BF4] results in an instantaneous colour change from yellow to dark green from which the fluorinated vinylidene complex [Ru(n5- C5H5)(=C=CFPh)(PPh3)2][BF4], [2a][BF4], was isolated in excellent yield. When the reaction between [la] and [FTMP][BF ] was performed in an NMR tube using CD2C12 solution, [2a][BF ], was found to be the sole phosphorus-containing product from the reaction. Complex [2a][BF ] could also be prepared in a one-pot procedure by treatment of the related vinylidene [Ru^5-C5H5)(=C=CHPh)(PPh3)2]+, [17a]+, with base to generate [la] in situ followed by reaction with [FTMP][BF ]. In a similar vein, reaction between [Ru(n5- C5H5)(-C≡C-C6H4-4-R)(PPh3)2], (R = CF3 [lb], R = OMe [lc]), with [FTMP]BF gave [Ru^5-C5H5)(=C=CFC6H4-4-R)(PPh3)2][BF4] (R = CF3 [2b][BF4], R = OMe [2c][BF4]). Analogous reactivity to form [Ru^5-C5H5)(dppe)(=C=CPhF)][NSI], [2edppe][NSI], was also observed on the addition of NFSI to [ladppe].
The identity of [2a][BF ] was confirmed by a combination of NMR spectroscopy, mass spectrometry and X-ray diffraction. In addition to the signals for the [BF ] counter-anion, the 19F NMR spectrum of [2a][BF4] contained a singlet resonance at δ -208.7 and in the uC{1n} NMR spectrum resonances for the vinylidene ligand were observed at as doublet of triplets δ 389.0 (2JCF = 39.3 Hz, 2Jcp = 16.2 Hz) for the metal-bound carbon atom and a doublet at δ 196.7 JCF = 222.1 Hz). The fluorine-carbon couplings confirm the incorporation of the halogen into the organic ligand. It should be noted that these resonances are shifted ca. 30 ppm and 70 ppm downfield respectively when compared to the hydrogen- substituted analogue [17a]+ and that the metal bound carbon is observed at one of the lowest reported.
Figure imgf000024_0001
[1 b] R = C6H4-4-CF3 [2b][BF4] R = C6H4-4-CF3
[1c] R = C6H4-4-OMe [2c][BF4] R = C6H4-4-OMe
[1d] R = 'Bu [2d][NSI] R = ¾u*
* NFSI, Toluene, 0 °C, 45 min
Anion metathesis with an excess of NaPF6 led to the formation of [2a][PF6]. Crystals of this salt were grown by slow diffusion of Et20 into a CH2C12 solution of the complex. Two separate batches of crystalline [2a][PF6] were obtained one green, the other orange. Analysis of the two different sets of crystals by X-ray diffraction indicated that the [2a]+ cation was present in both cases, however, the orientation of the vinylidene ligand differed. As shown in Figure 1(a), for the green crystals, the fluorine substituent is orientated away from the cyclopentadienyl ring, whereas in Figure 1(b), the orange crystals, it is in the opposite orientation. There is a marked change in the geometry around the vinylidene ligand between the two isomers of the [2a]+ cation. In the case of the orange crystals, the angles around the β-carbon exhibit a marked deviation from the idealised sp2-hybridized geometry (C(6)-C(7)- F(l) 114.70(16) °, C(6)-C(7)-C(8) 132.55(17) °, C(8)-C(7)-F(l) 112.69(15) °,∑ = 359.94°), which when compared to the green isomer (C(6)-C(7)-F(l) 121.05(13) °, C(6)-C(7)-C(8) 121.02(13) °, C(8)-C(7)-F(l) 117.72(12) °,∑ = 359.79) indicate that the fluorine atom in the orange isomer is much closer to the metal-bound carbon atom of the ligand. Indeed, in the orange isomer, the vinylidene ligand shows a significant distortion from linearity (Ru(l)- C(6)-C(7) 164.20(15) °) whereas in the green isomer it is more typical for ruthenium vinylidene complexes (172.46(12) °). It should also be noted that the orientation of the phenyl substituent also changes between the two isomeric forms, notably in the green crystals the ring lies perpendicular to the plane of the vinylidene.
In order to gain further insight into the difference between the two isomeric forms of the complexes, the UV-visible spectra of the complexes were recorded in both the solid state (Figure 2a) and in CH2CI2 solution (Figure 2b). The spectra showed a difference in the position of max in the visible region (green 692 nm, orange 742 nm). The UV-visible spectra recorded after dissolution of both batches in CH2CI2 solution were essentially identical (Figure 2b). When coupled with the fact that only one species is observed in the NMR spectra of the complex, it is concluded that the two crystalline forms convert to the same species in solution.
In a similar manner to electrophilic fluorination, the electrophilic incorporation of -CF3 groups into the framework of organic compounds is also desirable as it is frequently been used to inhibit hydrolysis of specific sites within drug molecules. With this in mind, the reaction between [la] and Umemoto's reagent, (a source of "CF3 +") was shown to result in the selective formation of [Ru^5-C5H5)(=C=CCF3Ph)(PPh3)2][BF4], [12][BF4]. The 13C{1H} NMR spectrum of [12][BF4] again indicated the presence of a vinylidene ligand with a triplet of quartets resonance at δ 340.0 (2Jpc = 15.2 Hz, CF = 3.3 Hz,) and the structure was confirmed by a single crystal X-ray diffraction study. Therefore the addition of electrophilic fluorinating agents to ruthenium half- sandwich compounds appears to be a general pathway for the formation of both C-F and C-CF3 bonds. It is evident from the NMR and absorption spectra that the introduction of a fluorine- sub stituent into the vinylidene ligand has a pronounced effect on the electronic structure of the complex when compared to the [17a]+ and [12]+. Notably in the 13C NMR spectrum there is a low field shift in resonance for the metal bound carbon and the lowest energy transition in the absorption spectrum is red-shifted (Table 1). In order to gain further insight into this effect halo-vinylidene complexes [Ru(rj5-C5H5)(=CC{E}C6H4-4-R)(PPh3)2]X were prepared (E = CI, R = H [17b'][BF4]; E = Br, R = H [17c][BF4]; E = Br, R = Br [17d][Br3]; E = I, R = H [17e][I3]) and details of their absorption and NMR spectra are presented in Table 1. In addition, the absorption spectra for all of the complexes were simulated using Time- Dependent Density Functional Theory.
Table 1
Figure imgf000026_0001
Table 1 Summary of C NMR data and lowest energy bands in the absorption spectra of vinylidene complexes. Experimental data were recorded at a concentration of ca. 1 mmol dm"3 in CH2CI2 solution. * Denotes lowest energy absorption band not the band displaying maximum absorption. In the case of both mono- ([Ru(n5-L)(=CCHR)(PR3)2]+) (L = C5H5, R1 = Me;26 C9H7, R1 = Ph)27 and di- substituted [Ru^5-C5H5)(=C=C{R}Ph)(dppe)]+ vinylidenes,28 reaction with NCMe has been shown to be a versatile route to reverse the alkyne-vinylidene transformation and generate [Ru(n5-L)(NCMe)(PPh3)2]+, (L = C5H5, [18]+) and the corresponding alkynes HC≡CR and PhC≡CR respectively. These studies have also permitted detailed kinetic insight into the nature of the alkyne-vinylidene interconversion.26-28 However, heating a sample of
[2a]+ in NCMe-d3 did not result in analogous reaction to form [18]+ and FC≡CPh. In this case, the major product from the reaction was [14a]BF4 in which activation of one of the PPh3 ligands and subsequent combination with the fluorovinylidene ligands has occurred. The 31P NMR spectrum of the reaction provides evidence that this is the case as two resonances were observed at δ 46.6 (dd, JPF = 48.6 Hz; 2JPP = 4.2 Hz) and δ 42.3 (dd, JPF = 16.2 Hz; 2JPp = 4.7 Hz). The nature of the couplings to fluorine were confirmed by the observation of a resonance at δ -133.4 (ddd, JPF = 48.9 Hz; 2JPF = 16.2 Hz; HF = 16.2 Hz) and a matching resonance was observed in the 1H NMR spectrum at δ 4.69 (ddd, JHF = 17.1 Hz; JpH = 5.0 Hz; JPH = 1.7 Hz). The structure of [14a]BF4 was also assigned on the basis of the large P-F coupling to the resonance at δ 46.6. Although additional products were observed on protracted heating, a complex related to [14a]BF4 has been reported previous from the nucleophilic attack of PPh3 at a coordinated vinylidene.29 On heating a sample of [Ru^5-C5H5)(=C=CFPh)(dppe)]NSI [2adpPe][NSI] in d3-MeCN, no phosphine activation was observed. This is presumably due to the bidentate coordination mode of dppe which disfavours the initial phosphine loss and hence prevents analogous reactivity.
The formation of [14a] [BF ] demonstrates that the fluorovinylidene ligands is bound strongly to the ruthenium.
Figure imgf000028_0001
[2a][BF4] [14a][BF4]
Although it is possible to prepare dinuclear fluorovinylidenes by the activation of suitable fluorocarbons,30 the reaction between alkynyl complexes [1] with electrophilic fluorinating agent offers a highly selective and simply route for the direct formation of C-F and C-CF3 bonds without any apparent involvement of the metal centre. The fluorinated vinylidene complexes [2]+ prepared in the study are more robust that the chloro-, bromo- and iodo- substituted analogues, which in our hands frequently decomposed to give [Ru(n5- C5H5)(CO)(PPh3)2]+. When combined with their unique electronic structure and the fact that no conversion to the alkyne FC≡CR was observed, these complexes clearly offer the opportunity for the incorporation of additional functionality into the organic ligand to prepare novel fluorinated compounds.
Another illustrative example is the formation, and subsequent fluorination, of the ruthenium vinyl pyridylidene ([20][PF6]) and 1-ruthanaindolizine complexes [9] which are prepared by reaction of [Ru^5-C5H5)(PPh3)(Pyr)2][PF6], [19][PF6] with terminal alkynes.31
Figure imgf000029_0001
1 ,4-diazabicyclo[2.2.2]octane (DABCO)
DCM, 20 °C, 16 h
- [HDABCO]+
Figure imgf000029_0002
Reaction of [Ru( 5-C5H5)(PPh3)(Pyr)2][PF6] with terminal alkynes to form complexes [20][PF6] and [9].
C-F bond formation is promoted in the coordination sphere of Ru by treatment of [9] with a stoichiometric quantity of l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate ([FTMP][BF4]), FSI or Selectfluor® as a latent source of "F+". This resulted in the quantitative (by NMR) conversion of [9] to a new, bright-green complex characterised by single 31P{1H} (δ 47.2 ppm, 4JPF = 7.7 Hz) and r|5-C5H5 1H (5.37 ppm) resonances. The product also displayed a 19F resonance with a large HF coupling at δ -139.8 ppm ( HF = 52.0 Hz, 4JPF = 7.7 Hz). HRESIMS showed the presence of a cationic molecular ion at 696.1023 m/z, which is consistent with mono-fluorination of [9]. The spectroscopic data are not consistent with oxidative fluorination of the metal to form a Ru-F which would be expected to exhibit a significantly upfield 19F chemical shift of around δ -250 ppm. The magnitude of the observed HF coupling constant, which suggested two-bond coupling, and supported by X- ray crystallographic studies, indicates that electrophilic fluorination of [9] occurs at the 3- position on the 1-ruthanaindolizine ring leading to the formation of complex [10][BF4]. Fluorination of [9] to produce [10]+ was also possible using alternative electrophilic fluorinating agents, including Selectfluor® and NFS!
Figure imgf000030_0001
[9] [10]+
Reaction of [9] with l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate.
Single-crystal X-ray diffraction studies show the molecular structure of [10][BF4] to contain a metallocyclic ring system similar to that seen in [9], but with the formation of a new C-F bond at C(l 1). The M-C bond to the pyridylidene ring in [10][BF ] is of a similar length to that in 2 (1.990(2) compared to 1.996(2) A), whereas the Ru-C bond to C(12) is significantly shorter (1.916(2) compared to 2.046(2) A) consistent with an increase in double bond character upon fluorination. The C(l 1)-C(12) bond is elongated in [10][BF ] compared to [9] (1.508(3) vs. 1.339(2) A), which is consistent with the formal loss of double bond character. Overall the most appropriate Lewis structure for [10]+ appears to be that shown, which invokes pyridylidene (rather than pyridyl) character to the Ru-C(6) bond and Schrock-type carbene character to C(12). This is supported by BO analysis. Although the BO reference structure for the cation [10]+ is based on a Ru-C(6) single bond, there is significant donation of metal-based electron density to the C(6)-N(l) π* orbital (occupation = 0.483 e"; second order perturbation stabilisation energy = 83 kJ mol"1) which gives considerable π character to this M-C bond. The Ru-C(12) bond in [10]+ is described as a double bond in the NBO reference structure (π-bond occupancy = 1.815 e") and its Wiberg bond index is significantly larger than the equivalent Ru-C bond in [9] (1.067 vs. 0.665), consistent with significant Ru-C(12) multiple bond character in [10]+. Based on this Lewis structure Ru can be considered to have a formal oxidation state of +4 (with one Fischer-type and one Schrock- type carbene ligand present). As such, the electrophilic fluorination reaction is distinctly different from other previously reported metal-mediated electrophilic fluorination reactions.1 It is oxidative (with regard to the metal), which is similar to related Pd chemistry,1 but different to non-redox electrophilic fluorination reactions promoted by Lewis acidic metals (e.g. Ti).1 However, unlike in the Pd cases the reaction produces an outer-sphere fluorination product, which we believe occurs without the involvement of a Ru-F intermediate.
Fluorination of the 3 -position on the 1-ruthanaindolizine ring in racemic [9] leads to the creation of a new stereogenic carbon centre C(l l) in [10][BF4]. The reaction is diastereoselective, leading only to the diastereomer in which the C-F bond points towards the C5H5 ring. This is supported by NOESY experiments that show no cross-peak between H(l l) and the hydrogen atoms of the C5H5 ring. The single-crystal X-ray structure of
[10][BF4] is enantiopure, containing only the RR enantiomer. This diastereoselectivity is driven by sterics: "F+" addition to the "inside" face of the 1-ruthanaindolizine ring is blocked by the three Ph groups on the phosphine. This is likely to be a kinetic, rather than thermodynamic, effect as the products of "F+" addition to the two faces are found to be essentially isoenergetic (-194 and -192 kJ mol"1 for the "outside" and "inside" faces respectively, relative to [9] and [FTMP]+) in DFT studies {vide infra). The geometry around C(l l) is slightly distorted from ideal tetrahedral geometry and the C(l l)-F(l) bond length is rather long for a typical sp3 hybridised C-F bond at 1.403(2) A. Further reactivity of [10] [BF4]
Interestingly, [10][BF4] is susceptible to further electrophilic fluorination. When 2 equiv. of [FTMP][BF4] are added to [9] in dichloromethane, [10][BF4] is observed to form immediately in the NMR spectra and over a period of 24 h this species converts cleanly to a new complex [21][BF4]. The characteristic 19F resonance for F(l) of [10][BF4], observed at δ -139.8 ppm (dd, HF = 52.0 Hz, PF = 7.7 Hz), is replaced by two 19F resonances at δ -96.6 (d, 2JFF = 233.1 Hz) and δ -78.0 (dd, 2JFF = 233.1 Hz, 4JPF = 6.6 Hz) ppm, which are strongly mutually coupled. HRESIMS showed the presence of a cationic molecular ion at 714.0920 m/z, which indicated that net deprotio-difluorination of [9] had taken place. The spectroscopic data and a subsequent single-crystal X-ray diffraction study showed that geminal difluorination of the 3 -position on the 1-ruthanaindolizine ring in 2 had taken place. This appears to occur as a two-stage process via formal "F+" addition to give [10][BF4] and subsequent C-H activation (presumably via deprotonation of [10][BF4] by free 2,4,6- trimethylpyridine (TMP) in the reaction mixture) and fluorination to give [21][BF4]. Indeed, reaction of isolated [10][BF4] with [FTMP][BF4] does afford [21][BF4].
Figure imgf000032_0001
r9i nor Γ21 Γ
Reaction of [9] with two equivalents of [FTMP][BF4]. Conditions: + 2 equiv. [FTMP][BF4], - TMP, -[HTMP][BF4], CH2C12 20°C, 24 hours.
The molecular structure of [21][BF4] displays similar metric parameters to [10][BF4], with a Ru-C(6) distance (2.010(3) A} that is similar to the parent metallocycle [9], but with a significantly shorter Ru-C(12) distance ( 1.902(3) A} compared to [9]. As with [10][BF4] this suggests some pyridylidene character at C(6) and significant Schrock-type carbene character at C(12) and both fluorinated products can be described by similar Lewis structures. The C-F bond lengths C(l l)-FQ) ( 1.374(3) A} and C(l l)-F(2) ( 1.353(3) A} in [21][BF4]are significantly shorter than in [10][BF4] and are more similar to typical sp3 C-F bond lengths, with slightly less distortion around C(l 1) from ideal tetrahedral angles.
Dissolution of [21][BF4]in d5-pyndine at room temperature led to the NMR signals associated with [21][BF ] slowly disappearing over the course of a week, along with the appearance of new signals attributed to [22 (31P δ = 61.4 ppm, 19F δ = -111.7 ppm), which is a fluorinated analogue of the 1-ruthanaindolizine complex [9]. The metallocycle [22] can also be formed independently by deprotonation of [10][BF ] with l,4-diazabicyclo[2.2.2]octane (DABCO) in CH2C12. However, in the presence of [H.DABCO][BF4] in CH2C12 [22] is in equilibrium with a new a-fluorovinyl pyridylidene complex [23][BF ] and free DABCO, which results in dynamic behaviour that is rapid on the NMR timescale at room temperature. Cooling this mixture to 195K was not sufficient to freeze out all dynamic behaviour, but broad signals at 19F δ = -112 and 31P δ = 62 ppm associated with [22] can clearly be seen. Similar dynamic behaviour has been observed for [9].31 The dynamic behaviour of [22] can be prevented by dissolution in a basic solvent such as d5-pyndine which allowed full characterisation by NMR spectroscopy.
Figure imgf000034_0001
[21 r [22] [23]+
Further reactivity of [21][BF4]. (i) d5-pyridine, 20 °C, 7 days, (ii) + DABCO, -[H.DABCO][BF4], CD2C12, 20°C or dissolution in d5-pyridine. (iii) Equilibrium in the presence of [H.DABCO][BF4] in CD2C12, 20°C.
Formation of [22] from [21][BF ] is a very unusual observation, as "F+" has formally been lost from the CF2 group in [21][BF4] to form the l-ruthana-3-fluoroindolizine ring. This surprising observation may be linked to the formation of an additional ruthenium- containing species [24][BF ] during this reaction. The signals from this complex are observed to grow in the NMR spectra (31P δ = 43.2 ppm, 19F δ = -78.7 (d, 2JFF = 208.5 Hz) and -67.6 (d, 2JFF = 208.5 Hz) ppm) as the metallocycle [22] is formed (in an approximately 1 :0.7 ratio of [22] to
[24][BF ], based on 19F NMR integration). The presence of two, strongly mutually coupled fluorine environments suggests that the geminal CF2 group is retained in [24][BF ] and that the symmetry of the system is such that these two fluorine atoms are chemically inequivalent. However, in contrast to [21][BF ] no P-F coupling is observed for either fluorine of the CF2 group in [24][BF ]. The mass spectrum of this reaction clearly shows the presence of [22] and an additional ruthenium-containing species with m/z of 730.0872, assigned as [24][BF ]. The mass of this species suggests that [21][BF4] has gained a single oxygen atom during this transformation to form [24][BF4]. Although the precise nature of [24][BF4] has not been unambiguously determined, we tentatively propose the ketone-containing structure shown in the figure above, which is consistent with the spectroscopic data. If [24][BF ] were formed by hydration of [21][BF ] (by adventitious water present in the ds-pyridine) then H2 would formally be lost during this process. While it is unlikely that H2 gas is formed, hydration may be coupled to the formal loss of "F+" from [21][BF ] during the formation of [22] to give an overall balanced reaction as follows:
2 [21][BF4] + pyridine + H20 [22] + [24][BF4] + [H.pyridine][BF4] + HF
In support of this hypothesis, a broad N-H signal at δ 9.1 ppm, suggestive of [H. pyridine] [BF ], is seen in the 1H MR. The up field chemical shift of this proton compared to free [H. pyridine] [BF ] in pyridine and significant broadening of this signal can be attributed to dynamic proton exchange with [22] to form [23][BF ], in analogy to the [H.DABCO][BF ] reactivity described above. Although no evidence of HF (or related products) was seen in the spectra, it is possible that when formed this reacts with the glass reaction vessel and so is not visible in solution.
Mechanistic considerations
During the reactions above no Ru-F intermediates were observed spectroscopically. In order to investigate the possibility that a short-lived Ru-F intermediate is involved in the formation of [10][BF ] we undertook a low-temperature NMR study on the reaction and have probed the reaction mechanism using DFT studies. In the NMR study, [9] and [FTMP][BF ] were combined in CD2C12 at 195 K and introduced to a pre-cooled NMR spectrometer at 195 K. 1H, 31P and 19F spectra were recorded as the spectrometer temperature was warmed to 295 K. The reaction appears not to proceed at temperatures below 245 K but at 265 K the reaction is essentially complete, suggesting relatively fast kinetics even at low temperatures. No potential reaction intermediates (Ru-F containing species or others) were observed at any temperature during these studies, which suggests that "F+" is either directly transferred to the site of fluorination or that only low energy transition states connect any potential intermediates from the reaction product [10][BF4].
The mechanistic features of electrophilic fluorination reactions involving "F+" sources such as [FTMP][BF4] or Selectfluor® are the matter of some debate, and either single-electron transfer (SET) followed by rapid radical recombination or nucleophilic attack at the "F+" source seem likely to occur in different systems. A plot of the spin density of the radical cation [9]-+, which would be initially formed by 1 -electron oxidation of [9] by the fluorinating agent as part of a SET-based mechanism, shows significant spin density on the 3-position of the ruthanindolizine ring and no spin density on the 2-position. As such, a SET-based mechanism involving direct outer-sphere electrophilic fluorination (OSEF) of the 3-position of the ruthanindolizine ring would be consistent with the observed regiochemistry. However, this does not rule out the possibility of a mechanism involving nucleophilic attack of the carbon at the 3-position of the ruthanindolizine ring on the "F+" source.
DFT studies support the suggestion that the formation of [10] [BF4] does not proceed via a Ru-F complex and that direct fluorination of 9 is likely to be a low-energy process. The scheme below shows the potential energy surface (PES) for the possible fluorination products and their key interconversions.
Figure imgf000037_0001
Potential energy surface (PES) for the electrophilic fluorination reactions observed here. All data are at the PBE0-D3/def2-TZVPP//BP86/SV(P) level with solvation corrections applied in CH2C12 (COSMO, ε = 8.93 for CH2C12 at 25°C). ESCF+ZPE energies (relative to [9] and [FTMPf) are shown below each state and Gibbs energies at 298.15 K are given in brackets below these. [Ru] = [Ru(rj5-C5H5)(PPh3)].
It can be seen from the PES above that the formation of Ru-F-containing ions [27af and
[27b] is thermodynamically favoured over 9 and [FTMP]+ (by 158 kJ mol"1 and 208 kJ mol"1 respectively). However, the PES between these fluoride complexes and the observed product
[10]+ shows features that suggest that a Ru-F complex is not an intermediate in the formation of [10]+. [10]+ is not the thermodynamic product of "F+" migration from either Ru-F isomer to a carbon atom on the metallocycle. The thermodynamic product is [29Z]+, which is not observed experimentally, where the 2-position of the ruthanindolizine is fluorinated. [29Z]+ is also the kinetic product of "F+" migration, being formed via a transition state that lies 130 kJ mol"1 higher in energy than the Ru-F complex [27b]+. The calculations suggest that there is a very significant barrier (+204 kJ mol"1) to formation of the observed product [10]+ from
[27bf We assume here that interconversion between the two Ru-F isomers is possible and that the lowest energy isomer [27b]+ will be populated. Isomerisation to [27a]+ is then required to allow "F+" migration to form [10]+ with the observed stereochemistry. A barrier of this magnitude is not consistent with the rapid formation of [10]+ at 265 K, as seen in the low-temperature MR studies. The large barriers found in the DFT studies and suggestion that the unobserved complex [29Z]+ should be the favoured product from a Ru-F species suggests that another mechanism for the formation of [10]+ occurs in this system. Direct outer-sphere electrophilic fluorination (OSEF) of the 3-position of the ruthanindolizine ring in 2 seems likely. The PES for the formation of [21]+ from a Ru-F-containing intermediate is similar to that shown in the PES above and fluorination via an OSEF mechanism also seems likely here.
Direct fluorination of the 3-position of the ruthanindolizine ring in 9 by [FTMP]+ was investigated using relaxed PES scans (at the (RI-)PBE0/def2-TZVPP//(RI-)PBE0/SV(P) level) for the closed-shell singlet, triplet and singlet diradical states. The reaction pathways for all states proceed via relatively low energy barriers (AESCF* in CH2CI2 of 58, 27 and 23 kJ mol"1 respectively) to form [10]+, which is consistent with the fast reaction and lack of intermediates observed experimentally. Interestingly, the open-shell pathways are found be lower in energy than the closed-shell pathway, which suggests that a SET mechanism may operate in this system (although care should be taken in interpreting the energies of the singlet diradical states, due to spin contamination). In any event, the low barriers to fluorination directly at the ligand contrasts markedly with the large barriers for C-F bond formation via a metal-fluoride intermediate, supporting the proposal that the reaction proceeds by an outer-sphere mechanism.
The present invention will now be described by way of example only with reference to the accompanying figures in which:
Figure 1 illustrates the solid state structures of the [2a]+ cation found in (a) green crystals and (b) orange crystals. Hydrogen atoms removed for clarity and thermal ellipsoids (where shown) are at the 50 % probability level;
Figure 2 illustrates the UV- visible spectra of the two isomers of complex [2][PF6] recorded (a) in the solid state with the diffuse reflectance technique and (b) in CH2CI2 solution;
Figure 3 illustrates the variable temperature 19F NMR spectra of [10][BF4] and DABCO (CF3 region);
Figure 4 illustrates the variable temperature 19F NMR spectra of [10][BF4] and DABCO; Figure 5 illustrates the variable temperature 19F NMR spectra of [10][BF4] and DABCO (BF4 region);
Figure 6 illustrates the variable temperature 31P NMR spectra of [10][BF4] and DABCO;
Figure 7 illustrates the solid state structure of the cation [12]+, hydrogen atoms omitted for clarity, thermal ellipsoids (where shown) are at the 50 % probability level;
Figure 8 illustrates the solid state structure of the cation [10]+, most hydrogen atoms omitted for clarity, thermal ellipsoids (where shown) at the 50 % probability level;
Figure 9 illustrates the solid state structure of the cation [21]+, hydrogen atoms omitted for clarity, thermal ellipsoids (where shown) are at the 50 % probability level;
Figures 10(a) to (b) illustrate absorption spectra for certain specified complexes; and
Figures 11(a) to (d) illustrate solid state structures for certain specified complexes. Methods
General Methods
All air-sensitive experimental procedures were performed under an inert atmosphere of nitrogen using standard Schlenk line and glovebox techniques. Dichloromethane and pentane were purified with the aid of an Innovative Technologies anhydrous solvent engineering system. The CD2CI2 used for NMR experiments was dried over CaH2 and degassed with three freeze-pump-thaw cycles. The solvent was then transferred into NMR tubes fitted with PTFE Young's taps or stored under a nitrogen atmosphere in the Glove Box. NMR spectra were acquired on a Jeol ECX-400 (Operating frequencies 1H 399.78 MHz, 31P 161.83 MHz, 19F 376.17 MHz, 13C 100.53 MHz), a Bruker AVANCE 500 (Operating frequencies 1H 500.13 MHz, 31P 202.47 MHz, 19F 470.69 MHz, 13C 125.77 MHz) or a Bruker AVANCE 700 (Operating frequencies 1H 700.13 MHz, 31P 283.46 MHz, 13C 176.07 MHz). 31P and 13C spectra were recorded with proton decoupling. Assignments were confirmed with the aid of 2D-COSY, NOESY, HMQC and HMBC experiments. Mass spectra were recorded on a Bruker micrOTOF using electrospray ionisation.
Calculations were performed at the (RI-)PBE0/def2-TZVPP//(RI-)BP86/SV(P) level (a methodology that we have validated in a related system)32 with the full ligand substituents used in the experimental study using TURBOMOLE version 6.4. Data presented includes dichloromethane solvation (using the COSMO method with ε = 8.93 for dichloromethane at 25°C). Single-point DFT-D3 corrections (on the (RI)-BP86/SV(P) geometries) have been applied at the PBE0-D3 level using Grimme's DFT-D3 (V3.0 Rev 2, with BJ-damping) program and data includes this correction. Gas-phase data are provided in the supplementary information. Both ZPE-corrected SCF energies {ESCF+ZPE) and Gibbs energies at 298.15 K are shown and energies quoted are relative to [9] and [FTMP]+. ESCF+ZPE data are discussed in the main section of the manuscript due to the difficulty in assessing entropy changes in solution from gas-phase calculations. Minima were confirmed as such by the absence of imaginary frequencies, and transition states were identified by the presence of one imaginary frequency with subsequent verification by DRC analyses. Vertical excitation energies were calculated using the ESCF module of TURBOMOLE (full TDDFT) on the (RI-)PBE0/def2- TZVPP optimised structures at the same level of theory. Tight SCF convergence criteria were used in these calculations. 50 singlet excitations were calculated for each state.
Direct fluorination of the 2-position of the ruthanindolizine ring in 9 by [FTMP]+ was investigated using relaxed PES scans (at the (RI-)PBE0/def2-TZVPP//(RI-)PBE0/SV(P) level). It was found that BP86/SV(P) geometry optimisations, as used in the other computational studies here, did not describe the geometries close to the transition state for the singlet closed-shell potential energy surface well and use of the hybrid PBEO functional for geometry optimisations was required. PES scans involved scanning along the reaction coordinate where a molecule of [FTMP]+ approaches the 2-position of the ruthanindolizine ring in 9. A series of input structures were generated where the C-F bond that is being formed was constrained to distances of between 4.0 and 1.4 A in 0.2 A steps, this was the only constraint applied. The geometries of these constrained structures were then optimised for the closed-shell singlet, triplet and singlet diradical states. Broken-symmetry singlet diradical states were obtained from the optimised triplet geometries using the "flip" function of the TURBOMOLE "define" script. This allows the user to select a localised alpha spin orbital involving a particular atom (Ru in this case) to become a beta spin orbital (or vice versa) to generate a broken symmetry (S = 0) state. Once suitable starting MOs had been obtained using this method, the geometries of the singlet diradical states were optimised from this point. Mulliken population analyses were performed on the converged wave functions to check that these did indeed correspond to the desired singlet diradical states. A summary of these data are given in the tables below, along with optimised xyz coordinates for each point along the reaction coordinate.
Synthetic Procedures
Example 1
Synthesis of [Ru(ti5-C5H5)(PPh3)2(-C≡CPh)], [la]
Figure imgf000043_0001
Prepared as described in the literature.
Example 2
Synthesis of [Ru^5-C5H5)(PPh3)2(-C≡C-C6H4-4-CF3], [lb]
Figure imgf000043_0002
An oven-dried Schlenk tube was charged with Ru^5-C5H5)(PPh3)2Cl [7] (250 mg, 0.33 mmol), 4-ethynyl-a,a,a-trifluorotoluene (86 μΐ, 0.5 mmol) and methanol (15 mL), and heated under reflux for 30 minutes. The reaction mixture was cannula filtered to remove undissolved starting material. To the red solution was added NaOMe (27 mg, 0.5 mmol) as a methanol solution (2 mL), to yield a bright yellow precipitate. The solvent was removed by cannula filtration, and the yellow powder dried under vacuum. Yield = 211 mg (72 %). 1H NMR (CD2C12, 500 MHz, 295 K): δ 4.35 (s, 5H, Hi), 7.12 (t, 3JHH = 7.4 Hz, 12H, Hn), 7.16 (d, VHH = 8.3 Hz, 2H, H5), 7.24 (t, 3JHH = 7.4 Hz, 6H, H12), 7.39 (d, 2H, 3JHH = 8.3 Hz, H6), 7.42 - 7.49 (m, 12H, ¾0)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 85.4 (s, Ci), 114.3 (s, C3), 123.8 (q, 2JCF = 32.1 Hz, C7), 124.6 (q, 3JcF = 3.7 Hz, C6), 125.0 (q, lJCF = 270.2 Hz, C8), 125.9 (t, 2JCP = 24.6 Hz, C2), 127.3 (t, sum ofJCP = 9.0 Hz, Cn), 128.6 (s, C12), 130.3 (s, C5), 133.7 (t, sum ofJCP = 9.7 Hz, Cio), 134.1 (s, C4), 138.7 (m, lJCP + 3JCP = 42.1 Hz, C9)
19F NMR (CD2CI2, 471 MHz, 295 K): δ -63.3 (s, F)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 51.6 (s, PPh3)
ESI-MS (m/z): Expected for C5oH4oF3P2Ru = 861.1609; Observed: 861.1600 [M+H+] (Error = 0.9 mDa)
Elemental Analysis: C5oH39F3P2Ru Calc. /% C 69.84, H 4.57, Found /% C 69.36, H 4.43.
Example 3
Synthesis of [Ru(ti5-C5H5)(PPh3)2(-C≡C-C6H4-4-OMe)], [lc]
Figure imgf000044_0001
An oven-dried Schlenk tube was charged with Ru^5-C5H5)(PPh3)2Cl [7] (250 mg, 0.33 mmol), 4-ethynylanisole (66 mg, 0.5 mmol) and methanol (15 mL), and heated under reflux for 30 minutes. The reaction mixture was cannula filtered to remove undissolved starting material. To the red solution was added NaOMe (27 mg, 0.5 mmol) as a methanol solution (2 mL), to yield a bright yellow precipitate. The solvent was removed by cannula filtration, and the yellow powder dried under vacuum. Yield = 218 mg (78 %)
1H NMR (CD2C12, 500 MHz, 295 K): δ 3.77 (s, 3H, ¾), 4.32 (s, 5H, Hi), 6.72 (d, 3JHH = 8.8 Hz, 2H, H6), 7.05 (d, 3JHH = 8.8 Hz, 2H, H5), 7.11 (app. t, 3JHH = 7.6 Hz, 12H, ¾), 7.22 (t, 3JHH = 7.4 Hz, 6H, H12), 7.46-7.54 (m, 12H, ¾0)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 55.6 (s, C8), 85.5 (s, Ci), 112.1 (t, 2JCP = 24.9 Hz, C2), 113.6 (s, C3), 113.7 (s, C6), 123.9 (s, C4), 127.6 (t, sum ofJCP = 9.2 Hz, Cio/11), 128.8 (s, C12), 131.6 (s, C5), 134.2 (t, sum of JCP = 10.4 Hz, C10/n), 139.5 (m, Ρ + 3JCP = 42.0 Hz, C9), 156.4 (s, C7)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 51.6 (s, PPh3)
ESI-MS (m/z): Expected for C5oH43OP2Ru = 823.1827; Observed: 823.1841 [M+] (Error = 1.4 mDa)
Elemental Analysis: C5oH42OP2Ru Calc. /% C 73.07, H 5.15, Found /% C 72.70, H 5.11.
Example 4
Synthesis of [Ru^5-C5H5)(PPh3)2(-C≡C-H)], [Id]
Figure imgf000045_0001
Prepared as described in the literature. (M. I. Bruce and A. G. Swincer, Australian Journal of Chemistry, 1980, 33, 1471-1483.). Example 5
Synthesis of [Ru^5-C5H5)(PPh3)2(-C≡C-H)], [le]
Figure imgf000046_0001
To Ru(rj5-C5H5)(PPh3)2Cl [7] (250 mg, 0.34 mmol) suspended in tert-butanol (lOmL) was added ethynyltrimethylsilane (195 μΐ^, 1.36 mmol) and ammonium hexafluorophosphate (112 mg, 0.68 mmol). The mixture was heated at 105 °C for 4.5 hours or until 31P MR of the reaction mixture indicated completion. The light orange solid was filtered in air through sinter and washed with diethyl ether (ca. 20 mL). The yellow/orange powder was dissolved in minimum amount of dichloromethane and filtered into excess stirring diethyl ether. The powder was filtered again and dried. Yield = 257 mg.
To an oven dried Schlenk tube was added the [Ru(=C=CH2)^5-C5H5)(PPh3)2][PF6] (257 mg, 0.30 mmol) and l,8-bis(dimethylamino)naphthalene, N,N,N',N'-tetramethyl-l,8- naphthalenediamine (64 mg, 0.30 mmol), which were dissolved in dichloromethane (lOmL) and stirred at room temperature for 10 min. The solvent was removed in vacuo and a minimum amount of dichloromethane was added. The yellow solution was filtered and the filtrate was dried in vacuo to yield a yellow solid. Yield = 147 mg (69 %).
1H NMR (400 MHz, CD2C12, 295 K): δ 1.81 (t, 4JFP= 2.2 Hz, 1H, H2), 4.18 (s, 5H, ¾), 7.22 (m, 3 OH, Ph)
31P NMR (162 MHz, CD2C12, 295 K): δ 50.2 (s, PPh3). Example 6
Synthesis of [Ru( 5-C5H5)(dppe)Cl], [7dppe]
Figure imgf000047_0001
Prepared as described in the literature.
1H NMR (CD2C12, 500 MHz, 295 K): δ 2.36 - 2.51 (m, 2H, Hi0a/b), 2.56 - 2.73 (m, 2H, Hioa/b), 4.57 (s, 5H, Hi), 7.13 - 7.20 (m, 4H, ar), 7.26 - 7.35 (m, 6H, ar), 7.42 - 7.49 (m, 6H, ar), 7.88 - 7.95 (m, 4H, ar)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 27.1 (m, C10), 79.8 (t, JCP = 2.4 Hz, Ci), 128.2 (app. t, sum of Jcp = 9.4 Hz, C3/4/7/8), 128.4 (app. t, sum of JCP = 9.4 Hz, C3/4/7/8), 129.4 (s, C5/9), 129.9 (s, C5/9), 131.7 (app. t, sum ofJCP = 10.6 Hz, C3/4/7/8), 134.3 (app. t, sum ofJCP = 10.6
Figure imgf000047_0002
C2 and C6 could not be observed.
31P NMR (CD2CI2, 202 MHz, 295 K): δ 81.8 (s, PPh3)
ESI-MS (m/z): Expected for C3iH29ClNaP2Ru = 623.0374; Observed: 623.0392 [M+] (Error = 1.8 mDa) Example 7
Synthesis of [Ru(q5-C5H5)(dppe)(-C≡C-Ph)], [ladppe]
Figure imgf000048_0001
Prepared as described in the literature.
1H NMR (CD2C12, 500 MHz, 295 K): δ 2.24 - 2.38 (m, 2H, Hi6a/b), 2.60 - 2.78 (m, 2H, Hiea/b), 4.80 (s, 5H, Hi), 6.35 - 6.39 (m, 2H, H5), 6.77 - 6.82 (m, 1H, H7), 6.85 - 6.91 (m, 2H, H6), 7.23 - 7.34 (m, 10H, ar), 7.40 - 7.48 (m, 6H, ar), 7.88 - 7.95 (m, 4H, ar)
13C NMR (CD2CI2, 125 MHz, 295 K): 27.7 (m, Ci6a/b), 82.3 (t, JCP = 2.3 Hz, Ci), 1 1 1.4 (s, C3), 1 17.2 (2JCP = 25.9 Hz, C2), 122.8 (s, ar), 127.3 (s, ar), 127.6 (app. t, sum of Jcp = 10.0 Hz, C9/10/13/14), 127.9 (app. t, sum of JCP = 9.0 Hz, C9/10/13/14), 128.9 (s, ar), 129.3 (s, ar), 130.0 (s, C4), 130.1 (s, ar), 131.5 (app. t, sum ofJcp = 10.6 Hz, C9/10/13/14), 133.8 (app. t, sum ofJcp = 10.4 Hz, C9/10/13/14), 137.2 (m, C 2), 142.2 (m, Cm2)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 86.3 (s, PPh3) Example 8
Synthesis of [Ru^5-C5H5)(dppe)(=C=CPhF)] [NSI], [2adpPe] [NSI]
Figure imgf000049_0001
A Young's NMR tube was charged with [Ru^5-C5H5)(dppe)(-C≡C-Ph)] (26 mg, 38 μιηοΐ) and NFSI (12 mg, 38 μιηοΐ) in CD2CI2 (0.5 mL). An immediate colour change was observed from yellow to bright green. Quantitative conversion was observed by 1H and 31P NMR spectroscopy and samples were used directly without isolation or further purification.
1H NMR (CD2CI2, 500 MHz, 295 K): δ 2.80 - 3.00 (m, 4H, Hi6), 5.68 (s, 5H, Hi), 6.39 - 6.43 (m, 2H, H5), 6.96 - 7.04 (m, 3H, H6/7), 7.10 - 7.17 (m, 4H, ar), 7.21 - 7.26 (m, 4H, ar), 7.27 - 7.32 (m, 6H, ar), 7.34 - 7.44 (m, 10H, ar), 7.48 - 7.53 (m, 2H, ar), 7.76 - 7.77 (m, 2H, ar), 7.77 - 7.79 (m, 2H, ar)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 28.2 (m, C16), 94.5 (s, Ci), 122.4 (s, C5), 126.9 (s, ar), 128.1 (s, C7), 128.2 (s, ar), 128.8 (s, C6), 129.2 (app. t, sum ofJCP = 11.0 Hz, C9/10/13/14), 129.7 (app. t, sum ofJcp = 10.0 Hz, C9/10/13/14), 130.1 (s, ar), 131.7 (app. t, sum ofJcp = 10.8 Hz, C9/10/13/14), 132.1 (d, JCP = 4.0 Hz, ar), 132.8 (app. t, sum of JCP = 11.4 Hz, C9/10/13/14), 134.2 - 135.3 (m, ar, C8/i2), 146.9 (s, ar), 193.4 (dt, ^CF = 225.7 Hz, 3JCP = 6.3 Hz, C3), 385.0 (m, C2)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 77.9 (s, PPh3)
19F NMR (CD2CI2, 471 MHz, 295 K): δ -210.8 (s, F3) ESI-MS (m/z): Expected for C39H34FP2R.U = 685.1168; Observed: 685.1147 [M+] (Error 2.1 mDa).
Example 9
Synthesis of [Ru( 5-C5H5)(dppe)(-C(NC5H5)=C(C6H5)F)][NSI], [15dppe] [NSI]
Figure imgf000050_0001
An NMR tube was charged with [Ru^5-C5H5)(dppe)(=C=CPhF)][NSI] (15 mg, 23 μιηοΐ) and pyridine (1.8 μΐ, 23 μηιοΐ, 1 equiv.) in CD2CI2 (0.5 ml) and allowed to stand overnight, during which time a colour change was observed from green to red.
1H NMR (CD2CI2, 500 MHz, 295 K): δ 2.47 - 2.63 (m, 2H, Hi9a/b), 3.00 - 3.19 (m, 2H, Hi9a/b), 4.17 (s, 5H, Hi), 5.85 - 5.89 (m, 2H, ¾), 6.87 (app. t, 3JHH = 7.8 Hz, 2H, H9), 6.93 - 6.98 (m, 1H, ¾0), 7.22 - 7.33 (m, 11H, ar), 7.35 - 7.40 (m, 6H, ar), 7.48 - 7.54 (m, 3H, ar), 7.54 - 7.59 (m, 4H, ar), 7.76 - 7.82 (m, 8H, ar), 7.82 - 7.87 (m, 2H, H3), 7.94 (tt, 3JHH = 7.7 Hz, 4JHH = 1 4 Hz, 1H, H5)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 29.7 (m, C19), 85.0 (s, Ci), 127.0 (s, C21), 127.3 (s, C8), 127.4 (s, ar), 128.2 (s, C22), 128.4 (s, ar), 128.5 (s, C9), 128.7 (app. t, sum of JCP = 9.2 Hz, C12/13/16/17), 129.0 (app. t, sum of J = 10.0 Hz, Cuns/ m), 129.8 (s, C14), 130.2 (s, C18), 130.3 (s, C23), 131.5 (app. t, sum ofJ = 9.6 Hz, Cn/nnem), 132.5 (app. t, sum ofJ = 9.6 Hz, C12/13/16/17), 137.4 (s, Cii/is), 142.6 (s, Cn/is), 142.7 (s, C5), 145.0 (s, C3), 146.7 (s, C20), 151.9 (dt, 2JCF = 84.7 Hz, 2JCP = 16.4 Hz, C2), 161.6 (dt, ^CF = 228.1 Hz, 3JCP = 3.9 Hz, C6) C7 and Cio could not be observed.
31P NMR (CD2CI2, 202 MHz, 295 K): δ 91.1 (d, 4JCF = 14.5 Hz, dppe)
19F NMR (CD2CI2, 471 MHz, 295 K): δ -82.1 (t, 4JCF = 14.5 Hz, F6)
ESI-MS (m/z): Expected for C44H39F P2RU = 764.1580; Observed: 764.1563 [M+] (Error = 1.7 mDa)
Example 10
Synthesis of [Ru( 5-C5H5)(dppe)(-CF=C(C6H5)F)], [6dppe]
Figure imgf000051_0001
An NMR tube was charged with [Ru^5-C5H5)(dppe)(CC{Ph}F)][NSI] (15 mg, 23 μιηοΐ) and TREAT.HF (3.7 μΐ, 23 μιηοΐ, 1 equiv.) in CD2C12 (0.5 ml) and allowed to stand for 30 minutes, during which time a colour change was observed from green to yellow.
1H NMR (C4D80, 500 MHz, 295 K): δ 2.56 - 2.80 (m, 4H, Hi6), 4.65 (s, 5H, Hi), 6.75 (tt, 3JHH = 7.3 Hz, 4JHH = 1.3 Hz, 1H, H7), 6.79 - 6.84 (m, 2H, H5), 6.90 (app. t, 3JHH = 7.6 Hz, 2H, H6), 7.20 - 7.32 (m, 16H, dppe), 7.77 - 7.83 (m, 4H, dppe)
13C NMR (C4D80, 125 MHz, 295 K): δ 30.1 (m, C16), 84.1 (s, Ci), 124.0 (t, 3JCF = 22.6 Hz, C5), 124.0 (s, C7), 127.5 (d, 4JCF = 1.9 Hz, C6), 128.1 (app. t, sum of J = 10.4 Hz, C9/io/i3/i4), 128.4 (app. t, sum of J = 9.0 Hz, C9/io/i3/i4), 129.1 (s, Cn/is), 129.7 (s, Cn/is), 131.6 (app. t, sum of J = 9.8 Hz, C9/10/13/M), 133.9 (app. t, sum ofJ = 10.7 Hz, C9/10/13/M), 134.6 (d, 2JcF = 30.7 Hz, C4), 138.0 (m, C8/i2), 145.2 (m, C8/i2), 159.5 (dd, ¥ = 198.1 Hz, 2JCF = 50.4 Hz,
C3), 187.9 (ddt, \½ = 296.6 Hz, 2JCF = 90.4 Hz, 3JCP = 18.2 Hz, C2)
31P NMR (C4D80, 202 MHz, 295 K): δ 94.3 (dd, 3JPF = 28.1 Hz, 4JPF = 2.6 Hz, dppe)
19F NMR (C4D80, 471 MHz, 295 K): δ -147.8 (d, 3JFF = 111.5 Hz, F3), -82,4 (dt, 3JFF = 111.5
Figure imgf000052_0001
ESI-MS (m/z): Expected for C39H34F2P2Ru = 705.1220; Observed: 705.1192 [M+H+] (Error = 2.8 mDa)
Example 11
Synthesis of 4]
Figure imgf000052_0002
An oven-dried ampoule was charged with [Ru(rj5-C5H5)(PPh3)2(-C≡CPh)] [la] (297 mg, 0.38 mmol) in dichloromethane (10 mL). l-Fluoro-2,4,6-trimethylpyridinium tetrafluoroborate (77.9 mg, 0.34 mmol) was added, and an immediate colour change was observed from yellow to green. The volume of solvent was reduced under vacuum to approximately 0.5 mL, and a green solid precipitated on the addition of excess diethyl ether. The solvent was then removed by cannula filtration and the dark green solid washed with diethyl ether, then dried under vacuum. Yield = 250 mg (82 %). 1H NMR (CD2C12, 500 MHz, 295 K): δ 5.45 (s, 5H, Hi), 6.98 - 7.05 (m, 14H, H9/10, H5/6), 7.22 - 7.28 (m, 13 H, H9/10, H7), 7.34 (t, J = 7.6 Hz, 2H, H5/6), 7.40 - 7.46 (t, 3JHH = 7.4 Hz, 6H, H„)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 96.7 (s, Ci), 122.3 (s, C5/6), 124.3 (s, C5/6), 129.1 (s, C7), 129.1 (t, sum of JCP = 10.6 Hz, C9/10), 131.6 (s, Cn), 133.6 (t, sum of JCP = 10.6 Hz, C9/10), 139.0 (m, C8), 150.7 (s, C4), 196.7 (d, ^CF = 222.1 Hz, C3), 389.0 (dt, 2JCF = 39.3 Hz,
Figure imgf000053_0001
19F NMR (CD2CI2, 471 MHz, 295 K): δ -208.7 (s, F3), -153.7 (BF4 ")
31P NMR (CD2CI2, 202 MHz, 295 K): δ 42.1 (s, PPh3)
ESI-MS (m/z): Expected for C49H40FP2Ru = 811.1627; Observed: 811.1656 [M+] (Error = 2.9 mDa)
Elemental Analysis: C49H40BF5P2Ru Calc. /% C 65.56, H 4.49, Found /% C 65.32 H 4.74.
Example 12
Synthesis of [Ru(q5-C5H5)(PPh3)2(=C=CFC6H4-4-CF3)] [BF4], [2b] [BF4]
Figure imgf000053_0002
An oven-dried ampoule was charged with Ru^5-C5H5)(PPh3)2(-C≡C(C6H4-4-CF3)) [lb] (148 mg, 0.17 mmol) in dichloromethane (5 mL). l-Fluoro-2,4,6-trimethylpyridinium tetrafluoroborate (35.2 mg, 0.15 mmol) was added, and an immediate colour change was observed from yellow to green. The volume of solvent was reduced under vacuum to approximately 0.5 mL, and a green solid precipitated on the addition of excess pentane. The solvent was then removed by cannula filtration and the dark green solid washed with diethyl ether, then dried under vacuum. Yield = 124 mg (75 %).
1H NMR (CD2C12, 500 MHz, 295 K): δ 5.50 (s, 5H, Hi), 6.99 - 7.06 (m, 14H, H5, Hio/n), 7.24 - 7.31 (m, 12H, H10/n), 7.44 (t, 3JHH = 7.3 Hz, 6H, H12), 7.50 (d, 3JHH = 8.3 Hz, 2H, H6) 13C NMR (CD2CI2, 125 MHz, 295 K): δ 96.7 (s, Ci), 122.6 (s, C5), 123.9 (q, \½ = 270.9 Hz, C8), 125.4 (q, 3JcF = 3.8 Hz, C6), 128.6 (t, sum of JCP = 10.5 Hz, Cio/11), 129.5 (q, 2JCF = 32.1 Hz, C7), 131.5 (s, C12), 132.9 (m, \½ + 3JCP = 52.7 Hz, C9), 133.3 (t, sum ofJCP = 10.4 Hz, Cio/11), 195.5 (d, CF = 221.0 Hz, C3), 383.5 (m, C2); C4 cannot be observed.
19F NMR (CD2C12, 471 MHz, 295 K): δ -212.1 (s, F3), -153.8 (BF4 "), -64.1 (s, F8)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 41.0 (s, PPh3)
ESI-MS (m/z): Expected for C5oH39F4P2Ru = 879.1501; Observed: 879.1540 [M+] (Error = 3.9 mDa)
Elemental Analysis: C5oH39BF8P2Ru Calc. /% C 62.19, H 4.07, Found /% C 61.70, H 4.36.
Example 13
Synthesis of [Ru(q5-C5H5)(PPh3)2(=C=CFC6H4-4-OMe)] [BF4], [2c][BF4]
Figure imgf000054_0001
An oven-dried ampoule was charged with Ru(rj5-C5H5)(PPh3)2(-C≡C(C6H4-p-OMe)) [lc] (183 mg, 0.22 mmol) in dichloromethane (5 mL). l-Fluoro-2,4,6-trimethylpyridinium tetrafluoroborate (45.0 mg, 0.20 mmol) was added, and an immediate colour change was observed from yellow to green. The volume of solvent was reduced under vacuum to approximately 0.5 mL, and a green solid precipitated on the addition of excess pentane. The solvent was then removed by cannula filtration and the dark green solid washed with pentane, then dried under vacuum. Yield = 144 mg (70 %).
1H NMR (CD2C12, 500 MHz, 295 K): δ 3.81 (s, 3H, ¾), 5.37 (s, 5H, Hi), 6.89 - 6.92 (m, 2H, H6), 6.95 - 7.03 (m, 14H, H10/n, H5), 7.23 (app. t, 3JHH = 8.1 Hz, 12H, H10/n), 7.42 (t, 3JHH = 7.4 Hz, 6H, H12)
13C NMR (CD2C12, 125 MHz, 295 K): δ 55.4 (s, C8), 96.3 (s, Ci), 114.5 (s, C6), 127.0 (s, C5),
128.7 (t,∑J = 10.8 Hz, C10/n), 131.2 (s, C12), 133.2 (t,∑J = 10.6 Hz. C10/n), 133.2 (m, C9),
160.8 (s, C7), 195.6 (d, 2JCF = 225.4 Hz, C3), 389.9 (m, C2)
C4 could not be observed.
19F NMR (CD2C12, 471 MHz, 295 K): δ -212.1 (s, F3), -153.8 (BF4)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 42.8 (s, PPh3)
ESI-MS (m/z): Expected for C50H42FOP2RU = 841.1733; Observed: 841.1749 [M+] (Error = 1.6 mDa)
Elemental Analysis: C50H42BF5OP2RU Calc. /% C 64.73, H 4.56, Found /% C 64.206, H 4.863. Example 14
Synthesis of [Ru^5-C5H5)(PPh3)2(=C=CFiBu)] [NSI], [2d] [NSI]
Figure imgf000056_0001
To an oven dried Schlenk tube [Ru^5-C5H5)(PPh3)2(-C≡C-tBu)] [Id] (120 mg, 0.15 mmol) was added followed by toluene (ca. 10 mL) and cooled to 0°C. Separately a solution of FSI (58 mg, 0.18 mmol) in toluene was cooled to 0°C and added to the cold ruthenium solution. The solution was stirred for 15 minutes at 0°C before being allowed to warm to room temperature over 1 hour. The toluene was removed in vacuo and the green residue washed with toluene (1 x 5 mL) and pentane (2 x 5 mL). The green solid was dried in vacuo to yield the desired product. Yield = 138 mg (82 %).
1H NMR (CD2C12, 500 MHz, 295 K): δ 1.03 (s, 9 H, H5), 5.30 (s, 5 H, Hi), 6.97 (dd, 3JHH = 8.0, 10.2 Hz, 12 H, H7), 7.26 (t, 3JHH = 7.3 Hz, 12 H, ¾), 7.43 (t, 3JHH = 7.3 Hz, 6 H, H9) 13C NMR (CD2CI2, 125 MHz, 295 K): δ 27.6 (s, C5), 33.2 (d, 3JCF = 24.9 Hz, C4), 96.1 (s, Ci), 129.0 (t, 3JCP + 5JcP = 5.0 Hz, C8), 130.8 (s, C9), 133.7 (t, 3JCP + 5JCP = 5.1 Hz, C8), 134.1 (m, C6), 204.9 (d, 'JcF = 228.9 Hz, C3), 392.6 (d, 3JCF = 49.6 Hz, C2)
19F NMR (CD2CI2, 376 MHz, 295 K): δ -216.9 (s, F3)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 39.4 (s, PPh3)
ESI-MS (m/z): Expected for C47H44FP2Ru = 791.1940; Observed: 791.1914 [M+] (Error = 2.6 mDa)
Elemental Analysis: C47H44F7P3Ru Calc. /% C 60.32, H 4.74, Found /% C 60.10, H 4.71 UV-Vis: Xcaax = 664 nm, ε = 715 mol"1 dm2 at a concentration of approximately 1 mmol dm' and a path length of 1 cm; calculated 655 nm
Example 15
Synthesis of
Figure imgf000057_0001
33
Prepared as described in the literature
Example 16
Synthesis of
Figure imgf000057_0002
An oven dried Schlenk tube was charged with [RuCp*(PPh3)2(=C=CFH)][BF4] [4a] (100 mg, 0.1 1 mmol) and dissolved in THF (ca. 5 mL). An oven dried ampoule was charged with lithium bis(trimethylsilyl)amide (90 mg, 0.54 mmol) and dissolved in TFIF (ca. 5 mL). Both solutions were cooled to -78 °C and the lithium bis(trimethylsilyl)amide solution was transferred via cannula into the vinylidene solution. The reaction mixture was stirred for 20 minutes at -78 °C before being allowed to warm to room temperature over a further 20 minutes. The solvent was removed in vacuo, and the solid washed with pentane (ca. 5 mL). The solvent was removed in vacuo and this process was repeated once more to remove residual THF. A yellow solution was extracted using pentane (2 x 15 mL) and filtered via cannula. The solvent was removed in vacuo yielding a yellow solid. The yield was not determined (approximately 25 mg).
1H NMR (C6D6, 500.2 MHz, 295 K): δ 1.22 (bs, H2), 6.86 (bs, H7), 6.99 (bs, H8/6), 7.70 (bs, ¾/8).
Selected 13C NMR (C6D6, 125.8 MHz, 295 K): δ 9.5 (s, C2), 92.6 (t, 2JCP= 2.0 Hz, Ci), 94.2
(d,
Figure imgf000058_0001
12.2 Hz,
C6), 138.0 ppm (t, P +
Figure imgf000058_0002
18.5 Hz, C5)
19F NMR (C6D6, 376.2 MHz, 295 K): δ -186.9 (t, 4JPF= 5.0 Hz)
31P NMR (C6D6, 161.8 MHz, 295 K): δ 50.9 (d, 4JPF= 5.0 Hz)
IR (ATR, υ/ cm"1): 1959 (C≡C)
ESI-MS (m/z): Expected for C48H46FP2Ru [M+H+]= 805.2096; Observed= 805.2083 [M + H+] (Error = 1.3 mDa)
Example 17
Synthesis of [Ru^5-C5Me5)(dppe)(-C≡C-H)], [3adpPe]
Figure imgf000058_0003
Prepared as described in the literature; sodium methoxide was used in place of sodium metal. (M. I. Bruce, M. A. Fox, P. J. Low, B. K. Nicholson, C. R. Parker, W. C. Patalinghug, B. W. Skelton and A. H. White, Organometallics, 2012, 31, 2639-2657)
Example 18
Synthesis of [Ru(ti5-C5Me5)(dppe)(-C≡C-F)], [3bdppe]
Figure imgf000059_0001
To an oven dried Schlenk tube [Ru^5-C5Me5)(dppe)(=C=CHF)][NSI] [6a] (195 mg, 0.22 mmol) was added followed by THF (ca. 10 mL) and cooled to -78°C. Separately a THF solution of lithium /s(trimethylsilyl)amide (33 mg, 0.20 mmol in ca. 5 mL) was cooled to - 78 °C and cannula transferred into the cold ruthenium solution. The solution rapidly turned yellow and left to stir for 15 min at -78°C, then allowed to warm up to room temperature. A yellow solution was extracted with pentane and the solvent removed in vacuo to yield a yellow solid. Yield = 44 mg (30 %).
1H NMR (CD2C12, 500 MHz, 295 K): δ 1.63 (t, 4JHP= 1.4 Hz, 15 H, H2), 1.86 (m, 2 H, ¾3), 2.58 (m, 2 H, H5), 7.06 (m, 8 H, H^), 7.24 (m, 8 H, H^), 7.83 (m, 4 H, H^)
Selected 13C NMR (CD2C12, 125 MHz, 295 K): δ 10.0 (s, C2), 29.3 (m, C13), 91.7 (s, Ci), 1 1 1.4 (d, 332.2 Hz, C4), 127.2 (t, J= 4.2 Hz, CAT), 128.6 (s, CAT), 128.7 (s, CAT), 133.3 (t, J= 5.2 Hz, CAT), 133.7 (t, J= 4.7 Hz, CAT), 137.3 (d, J = 46.5 Hz, CAT), 139.6 (d, J = 32.9
19F NMR (CD2C12, 376 MHz, 295 K): δ -189.4 (t, 4JFP= 4.8 Hz, F4) 31P NMR (CD2C12, 202 MHz, 295 K): δ 81.9 (d, 4JFP= 4.8 Hz, dppe)
ESI-MS (m/z): Expected for C38H39FP2RU = 678.16 m/z; Observed: 678.13 m/z [M+]
UV-Vis: Xcaax = 396 nm, ε = 10986 mol"1 dm2 at a concentration of approximately 1 mmol dm"3 and a path length of 1 cm; calculated
Figure imgf000060_0001
= 430 nm
Example 19
Synthesis of
An oven-drie
Figure imgf000060_0002
[3] (32 mg, 0.04 mmol) was dissolved in a mixture of acetonitrile (2.5 mL) and dichloromethane (2.5 mL), to which a solution of Selectfluor® (12 mg, 0.04 mmol) in acetonitrile (2.5 mL) added. The mixture was shaken vigorously for ca. 5 minutes and left to stand for 10 minutes before being filtered through cotton wool. The solvent was removed in vacuo to afford a blue solid. Yield = 12 mg (34 %).
1H NMR (500 MHz, CD2C12, 295 K): δ 1.28 (s, 15H, H2), 7.25 (m, 30H, Ph), 8.60 (d, 2JHF = 80.5 Hz, 1H, C4)
13C NMR (125.77 MHz, CD2C12, 295 K): δ 9.6 (s, C2), 107.3 (s, Ci), 128.3 (s, C6/7), 131.0 (s, C8), 133.7 (s, C6/7), 178.7 (d, \½ = 229.9 Hz, C4), 367.9 (s, C3).
19F NMR (471 MHz, CD2C12, 295 K): δ -236.1 (d, 2JHF = 80.5 Hz, F4), -152.9 (BF4)
31P NMR (202 MHz, CD2C12, 295 K): δ 51.5 (s, PPh3) ESI-MS (m/z): Expected for C46H48FP2Ru = 805.2097; Observed = 805.2101 [M+] (Error = 0.4 mDa)
Example 20
Synthesis of [Ru(ti5-C5Me5)(PPh3)2(=C=CF2)] [NSI], [4b] [NSI]
Figure imgf000061_0001
7
An oven dried Schlenk tube was charged with a benzene-d6 solution of [RuCp*(PPh3)2(- C≡CF)] (approximately 25 mg in 2-3 mL) and cooled down to -78 °C. To the cooled solution was added NFSI (66 mg, 0.21 mmol) in toluene (ca. 5 mL). The solution was stirred for 20 minutes at -78 °C, and then allowed to warm up to room temperature over 20 minutes. The resultant dark green reaction mixture was filtered via cannula and the black/dark green solid washed with pentane. The solid was dried in vacuo; the yield was not determined.
1H NMR (CD2C12, 399.8 MHz, 295 K): δ 1.27 (t, 3JHP= 1.4 Hz, 15H, H2), 7.00-7.35 ppm (m, ¾-¾).
19F NMR (CD2C12, 376.2 MHz, 295 K): δ -135.2 ppm (s).
31P NMR (CD2C12, 161.83 MHz, 295 K): δ 49.5 ppm (s).
MS-ESI (m/z): Expected for
Figure imgf000061_0002
823.2009 [M]+; Observed= 823.1996 [M]+ (1.3 mDa error) Example 21
Synthesis of [Ru^5-C5Me5)(dppe)(=C=CHF)] [NSI], [4adpPe] [NSI]
Figure imgf000062_0001
An oven dried Schlenk tube was charged with [RuCp*(dppe)(-C≡C-H)] [16] (160 mg, 0.24 mmol) which was then dissolved in toluene (ca. 5 mL) and cooled to -78°C. Separately a solution of NFSI (84.1 mg, 0.27 mmol) in toluene (ca. 5 mL) was prepared and added to the cold ruthenium solution. The solution was stirred for 15 minutes at -78°C before being allowed to warm to room temperature over lh. The green residue was isolated, and washed with toluene (lx 5 mL) and pentane (2 x 5 mL) before being dried in vacuo to yield a pale green solid. Yield = 195 mg (91 %).
1H NMR (CD2C12, 500 MHz, 295 K): δ 1.59 (s, 15 H, H2), 2.70 (m, 2 H, ¾3), 2.94 (m, 2 H, H13), 7.09 (dd, 3JHH = 10.8, 7.7 Hz, 4 H, HAT), 7.29 (m, 8 H, HAr), 7.32 (d, 2JHF= 80.2 Hz, 1 H, H4), 7.49 (t, 3JHH = 7.3 Hz, 8 H, HAT)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 9.8 (s, C2), 29.6 (m, C13), 105.6 (s, Ci), 128.9 (t, J=
5.4 Hz, CAT), 129.0 (t, J= 4.6 Hz, CAT), 130.6 (d, J = 48.2 Hz, CAT), 131.8 (s, CAT), 132.0 (s,
CAT), 132.1 (t, J= 5.3 Hz, CAT), 132.7 (t, J= 5.0 Hz, CAT), 134.5 (d, J= 58.0 Hz, CAT), 173.9 (d,
1JCF= 236.2 Hz, C4), 362.8 (d, 3JCF= 43.5 Hz, C3)
19F NMR (CD2CI2, 376 MHz, 295 K): δ -235.8 (d, 2JHF= 80.2 Hz, F4)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 76.4 (s, dppe)
ESI-MS (m/z): Expected for C38H4oFP2Ru = 679.1628 m/z; Observed: 679.1617 m/z [M+] (Error = 1.1 mDa) UV-Vis: Xcaax = 601 nm, ε = 546 mol"1 dm2 at a concentration of approximately 1 mmol dm and a path length of 1 cm; calculated = 580 nm
Example 22
Synthesis of [Ru^5-C5Me5)(dppe)(=C=CF2)] [NSI], [4bdpPe] [NSI]
Figure imgf000063_0001
An oven dried Schlenk tube was charged with [RuCp*(dppe)(-C≡C-F)] [23] (44 mg, 0.07 mmol) dissolved in THF (ca. 5 mL) and cooled to -78°C. Separately a solution of NFSI (22.7 mg, 0.08 mmol) in THF (ca. 5 mL) was prepared and added to the cold ruthenium solution. The solution was stirred for 15 minutes at -78°C before being allowed to warm up to room temperature over lh. The solvent was removed in vacuo and the purple/red solid washed with toluene (2x 5 mL) and pentane (2 x 5 mL). The solid was dried in vacuo to yield the desired product. Yield = 32 mg (55 %).
Selected 1H NMR (CD2C12, 500 MHz, 295 K): δ 1.56 (t, 4JHF= 1.3 Hz, 15 H, H2), 2.72 (m, 2 H, H13), 2.82 (m, 2 H, H13)
Selected 13C NMR (CD2C12, 125 MHz, 295 K): δ 9.8 (s, C2), 29.7 (m, C5), 106.9 (s, Ci), 231.3 (d,
Figure imgf000063_0002
22.5 Hz, C3)
19F NMR (CD2C12, 376 MHz, 295 K): δ -134.0 (s, F4)
31P NMR (CD2C12, 202 MHz, 295 K): δ 75.2 (s, dppe) ESI-MS (m/z): Expected for C47H44FP2R.U = 697.1543 m/z; Observed: 697.1545 m/z [M+] (Error = -0.2 mDa)
UV-Vis: Xcaax = 693 nm, ε = 677 mol"1 dm2 at a concentration of approximately 1 mmol dm"3 and a path length of 1 cm; calculated
Figure imgf000064_0001
= 698 nm.
Example 23
Synthesis of [Ru(ti5-C5Me5)(PPh3)2(=CFCHF2)] [BF4], [5] [BF4]
Figure imgf000064_0002
[Ru(n5-C5Me5)(PPh3)2(-C≡CH)], [3] (78.2 mg, 0.1 mmol) was partially dissolved in ca. 5 mL acetonitrile and ca. 0.5 mL dichloromethane. Separately, Selectfluor® (35.3 mg, 0.1 mmol) was dissolved in ca. 5 mL acetonitrile and added to the solution of [3]. The solution immediately turned dark brown. The yield was not determined.
Adventitious fluoride resulted in the formation of [Ru^5-C5H5)(PPh3)2(=CFCHF2)][BF4]
[5][BF4] contributing approximately 9% to the total ruthenium containing complexes in the reaction mixture.
1H NMR (CD2CI2, 500 MHz, 295 K): δ 1.32 (s, 15H, C2), 6.62 (td, 2JHF = 54.4 Hz, 3JHF = 18.6 Hz, 1H, H4), 7.25 (m, 30H, Ph) 19F NMR (CD2C12, 471 MHz, 295 K): δ -153.2 (BF4 "), -132.6 (dd, 3JFF = 29.8 Hz, 2JHF = 54.4
Hz, F4), 110.4 (dquin, 3JHF = 18.6 Hz, 3JPF,FF = 28.6 Hz, F3)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 46.5 (d, 3JPF = 26.6 Hz, PPh3)
ESI-MS (m/z): Expected for C48H46F3P2Ru = 843.2065; Observed: 843.2053 [M+] (Error = 1.2 mDa)
Example 24
Synthesis of (E)-[Ru(q5-C5H5)(PPh3)2(CF=CFPh)], [6]
Figure imgf000065_0001
An oven-dried ampoule was charged with [Ru^5-C5H5)(PPh3)2(=C=CPhF)][BF4], [2a][BF4] (50 mg, 0.56 μιηοΐ) and tetramethylammonium fluoride (5.2 mg, 0.56 μιηοΐ) in dichloromethane (10 mL) and left to stir for 3 days.
Alternative Procedure: A Young's NMR tube was charged with [Ru(n5- C5H5)(PPh3)2(=C=CPhF)][BF4], [2a][BF4] (20 mg, 0.02 mmol) and TREAT.HF (triethylamine trihydrofluoride, 3.6 μΐ, 0.02 mmol) in deuterated tetrahydrofuran (0.5 mL), and the reaction turned from green to yellow. The NMR spectra reported were recorded 5 days after addition.
1H NMR (C4D80, 500 MHz, 298 K): δ 4.39 (s, 5H, Hi), 6.81 - 7.82 (m, 50H, 13C NMR (C4D80, 126 MHz, 298 K): δ 160.8 (dd, lJ F = 197.3 Hz, 2JCF = 51.7 Hz, C2),
145.7 (dd, CF = 186.7 Hz, 2JCF = 21.3 Hz, C3), 140.4 (dd, JCF = 20.8 Hz, JCF = 19.3 Hz, C4),
139.8 (m, C8), 134.6 (app. t,∑JCP = 10.4 Hz, C9/10), 129.2 (s, Cn), 129.0 (s, C6/7), 127.9 (app. t,∑ Jcp = 9.2 Hz, C9/10), 124.3 (dd, 3JCF = 10.2 Hz, 4JCF = 8.2 Hz, C5), 85.8 (d, 3JCF = 1.8 Hz,
19F NMR (C4D80, 471 MHz, 298 K): δ -146.8 (d, 3JFF = 113.7 Hz, F3), -72.6 (dt, 3JFF = 113.7
Figure imgf000066_0001
31P NMR (C4D80, 162 MHz, 298 K): δ 52.5 (dd, 3JPF = 32.3 Hz, 4JPF = 2.4 Hz)
Example 25
Synthesis of [Ru^5-C5H5)(PPh3)2Cl], [7]
Figure imgf000066_0002
24
Prepared as described in the literature
Example 26
Synthesis of phenylacetyl fluoride, [8Ph]
Figure imgf000066_0003
5
An oven-dried Schlenk tube was charged with [Ru^5-C5H5)(PPh3)2(=C=CFPh)][BF4],
[2a][BF4] (230 mg, 0.26 mmol) and NBu4Cl (142 mg, 0.51 mmol) in dichloromethane (10 mL) and left to stir for one week. The reaction was monitored by NMR spectroscopy. [8Ph] can be isolated by sublimation using a cold finger filled with liquid nitrogen. The reaction is also possible using [Ru^5-C5H5)(PPh3)2(=C=CFPh)][NSI], [2a] [NSI] and [Ru(n5- C5H5)(dppe)(=C=CFPh)][NSI], [XXX] [NSI].
1H NMR (CD2C12, 500 MHz, 295 K): δ 3.66 (d, 3JHF = 1.6 Hz, 2H, H2), 7.25 - 7.37 (m, 5H, Ph)
19F NMR (CD2CI2, 471 MHz, 295 K): 6 42.5 (t, 3JHF = 1 6 Hz,
Example 27
Reaction of [Ru^5-C5H5)(dppe)(=C=CPhF)] [NSI], [2adppe] [NSI] with 2 equivalents of NnBu4Cl.H20
Figure imgf000067_0001
5
A Young's NMR tube was charged with [Ru^5-C5H5)(dppe)(=C=CPhF)][NSI] (30 mg, 30 μπιοΐ) and NBU4CI.H2O (17 mg, 60 μπιοΐ, 2 equiv.) in CD2CI2 (0.5 ml) and monitored by NMR spectroscopy. Immediately on addition of NnBu4Cl, conversion of [Ru(n5- C5H5)(dppe)(=C=CPhF)][NSI], [2adppe][NSI] to [Ru(n5-C5H5)(dppe)Cl], [7dppe] and a- fluorophenylacetaldehyde (PhCHFCHO, [8Ph']) was observed, a-fluoro-phenylacetaldehyde was identified by comparison of 19F NMR data with literature values. Selected 1H NMR (CD2C12, 400 MHz, 298 K): δ 9.72 (dd, 3JHF = 7.6 Hz, 5JHH = 0.7 Hz, Hi)
19F NMR (CD2C12, 376 MHz, 298 K): δ -191.7 (dd, 2JHF = 47.0 Hz, 3JHF = 7.6 Hz, Fi)
After 6 days, the NMR spectra were recorded again. The dominant organic product was phenylacetyl fluoride, [8Ph] .
Example 28
Synthesis of acetyl fluoride [8H]
Figure imgf000068_0001
A FEP lined Young's NMR tube was charged with [Ru^5-C5Me5)(dppe)(=C=CHF)][NSI], (10 mg, ) in acetonitrile-d3 (0.5 mL) was heated at 70°C in an FEP lined Young's NMR tube for 7 days.
19F NMR (CD2C12, 376.2 MHz, 295 K): δ 49.1 (q, JFH = 7.2 Hz)
Example 29
Synthesis of [Ru( -C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})], [9]
Figure imgf000069_0001
The synthesis was performed as described in the literature.31
Example 30
Synthesis of [Ru^5-C5H5)(PPh3)(C5H4NCHFC{C6H4-4-CF3})] [BF4], [10] [BF4]
Figure imgf000069_0002
9
An oven-dried ampoule was charged with [Ru( 5-C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})]
[9], (20 mg, 30 μιηοΐ) and dichloromethane (2 mL). l-Fluoro-2,4,6-trimethylpyridinium tetrafluoroborate (6.1 mg, 27 μιηοΐ) was added drop wise as a dilute solution in dichloromethane (5 mL). The solution was allowed to stir for ca. forty minutes until the colour change from brown to green was deemed complete, and the volume of solvent reduced under vacuum to 0.5 mL. An excess of pentane was added via a cannula transfer to produce a green precipitate. This residue was washed with pentane (2 x 10 mL), and dried under vacuum to yield a dark green precipitate.
Yield = 7 mg (30 %). Alternative procedures:
Fluorination with Selectfluor®: An oven-dried ampoule was charged with [Ru(n5- C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})] [9] (10 mg, 15 μιηοΐ) and dichloromethane (2 mL)., Selectfluor® (5 mg, 15 μιηοΐ) was added dropwise as a dilute solution in acetonitrile (2mL). The reaction mixture was stirred for ca. 60 minutes and then removed under vacuum. The green residue was redissolved in CD2CI2 (0.5 mL) and NMR spectra recorded.
Fluorination with NFSI: A Young's NMR tube was charged with [Ru(n5- C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})] [9] (10 mg, 15 μιηοΐ) and NFSI (5 mg, 15 μιηοΐ) in CD2CI2 (0.5 mL). NMR spectra were recorded after ca. 60 minutes.
1H NMR (CD2CI2, 500 MHz, 295 K): δ 4.71 (d, 2JHF = 52.1 Hz, 1H, Hn), 5.37 (s, 5H, Hi),
7.06 (apparent t, 3JHH = 6.8 Hz, 1H, H9), 6.12 - 7.19 (m, 6H, PPh3), 7.38 (d, 3JHH = 8.2 Hz, 2H, H14), 7.40 - 7.49 (m, 7H, PPh3, ¾), 7.49 - 7.56 (m, 3H, H5), 7.60 (d, 2H, 3JHH = 8.2 Hz, Hi5), 8.06 - 8.12 (m, 2H, ¾0, H7)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 93.5 (s, Ci), 115.9 (d, lJ F = 219.1 Hz, Cn), 120.0 (s, C9), 124.0 (s, CM), 124.5 (q, \½ = 272.8 Hz, Cn), 125.8 (q,3JCF = 3.8 Hz, Ci5), 129.4 (d, JCP = 10.7 Hz, C3/4), 131.0 (q, 2JCF = 32.65 Hz, Ci6), 132.0 (d, 4JCP = 2.4 Hz, C5), 132.1 (d, lJCP= 51.9 Hz, C2), 133.2 (d, JCP = 10.8 Hz, C3/4), 135.5 (s, C8), 140.3 (s, C7), 143.4 (d, 3JCF =
1.7 Hz, Cio), 211.8 (d, 2JCP = 15.9 Hz, C6), 301.4 (d, 2JCP = 8.1 Hz, Ci2)
Attempts to locate Ci3 using a range of NMR techniques were unsuccessful.
19F NMR (CD2CI2, 471 MHz, 298 K): δ -153.3 (BF4 "), -139.8 (dd, 2JHF = 52.0 Hz, 4JPF = 7.7 Hz, Fn), -64.2 (s, Fn)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 47.2 (d, 4JPF = 7.7 Hz, PPh3) ESI-MS (m/z): Expected for C37H29F4 P101 9Ru = 696.1012; Observed: 696.1023 [M+] (Error = 1.1 mDa)
Elemental Analysis: C37H29BF8 PRu Calc. /% C 56.79, H 3.74, N 1.79 Found /% C 56.347, H 3.727, N 1.738.
Example 31
Synthesis of [Ru( 5-C5H5)(PPh3)2(=C=C{C5H4N}Ph)] [BF4], [11a] [BF4]
Figure imgf000071_0001
A Young's NMR tube was charged with [Ru^5-C5H5)(PPh3)2(-C≡CPh)] [la] (40 mg, 45 μηιοΐ) and 1-f uoropyridinium tetrafluoroborate (8 mg, 45 μηιοΐ) in CD2CI2 (0.5 mL), and an immediate colour change was observed from yellow to red.
1H NMR (CD2CI2, 500 MHz, 295 K): δ 5.13 (s, 5H, Hi), 6.37 (dt, 3JHH = 8.0 Hz, 4JHH = 0.9 Hz, 1H, pyr) 6.74 - 7.53 (m, 68H, Ar), 7.86 (m, 1H, ¾).
13C NMR (CD2CI2, 125 MHz, 295 K): δ 96.4 (s, Ci), 120.5 (s, C5/7), 121.5 (s, C5/7), 128.6 (app. t, sum of J = 10.8 Hz, CM/IS), 129.2 (s, C12), 130.0 (Cio/11), 131.3 (s, Ci6), 131.7 (s, Cio/11), 134.2 (app. t, sum ofJ = 10.3 Hz, CM/IS), 136.2 (s, C3/9), 136.7 (s, C6), 148.4 (s, C8), 153.9 (s, C4) , 357.5 (t, 2Jcp = 16.2 Hz, C2). Carbons 3, 9 and 13 could not be assigned and may be obscured.
31P NMR (CD2CI2, 202 MHz, 295 K): δ 41.5 (s, PPh3) ESI-MS (m/z): Expected for Cs^M^R^ = 870.1987; Observed: 870.2024 [M+] (Error = 3.7 mDa).
Example 32
Synthesis of [Ru^5-C5H5)(=C=C{C5H4N}C6H4-4-CF3)(PPh3)2]BF4, [5b]BF4.
Figure imgf000072_0001
A Young's NMR tube was charged with [Ru ^-CsHsXPPhsM-^C-Cei^-CFs)] [lb] (20 mg, 23 μηιοΐ) and 1-fluoropyridinium tetrafluoroborate (4 mg, 23 μηιοΐ) in CD2CI2 (0.5 mL), and an immediate colour change was observed from yellow to red.
1H NMR (CD2CI2, 500 MHz, 295 K): δ 5.18 (s, 5H, Hi), 6.37 (dt, 3JHH = 8.0 Hz, 4JHH = 0.8 Hz, 1H, H5) 6.96 (ddd, 3JHH = 7.6 Hz, 3JHH = 4.8 Hz, 4JHH = 1.0 Hz, 1H, H7), 7.00 - 7.09 (m, 14H, H10, His/ie), 7.18 (m, 12H, H15/16), 7.40 (m, 6H, H17), 7.49 (app. td, 3JHH = 7.8 Hz, 4JHH = 1.6 Hz, 1H, H6), 7.55 (d, 3JHH = 8.1 Hz, 2H, H„), 8.00 (m, 1H, ¾)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 95.7 (s, Ci), 120.9 (s, C5), 122.0 (s, C7), 124.4 (q, \½ = 272.7 Hz, C13), 126.7 (q, ¥ = 3.5 Hz, Cn), 128.8 (app. t, sum of J = 10.5 Hz, C16), 131.5 (s, Cn), 133.0 (s, C10), 133.8 (m, C14), 134.1 (app. t, sum ofJ= 10.5 Hz, C15), 135.7 (s, C3), 137.1 (s, C6), 148.8 (s, C8), 153.4 (s, C4), 354,9 (t, 2JCP = 15.4 Hz, C2). Carbons C9 and Ci2 could not be assigned and may be obscured.
19F NMR (CD2C12, 376 MHz, 295 K): -62.6 (s, F13), -153.0 (BF4 ")
31P NMR (CD2CI2, 202 MHz, 295 K): δ 41.1 (s, PPh3)
ESI-MS (m/z): Expected for C55H43F3 P2Ru+ = 938.1876; Observed: 938.1858 [M+] (Error = 1.8 mDa).
Example 33
Synthesis of [Ru^5-C5H5)(PPh3)2(=C=CCF3Ph)] [BF4], [12][BF4]
Figure imgf000073_0001
An oven-dried ampoule was charged with [Ru^5-C5H5)(PPh3)2(-C≡CPh)], [la] (190 mg, 0.24 mmol) in dichloromethane (10 mL). 5-(Trifluoromethyl)dibenzothiophenium tetrafluoroborate (73 mg, 0.22 mmol) was added, and allowed to stir for 4 hours. The mixture was cannula filtered to remove any residual 5-(trifluoromethyl)dibenzothiophenium tetrafluoroborate, and the volume of solvent was reduced under vacuum to approximately 0.5 mL. A red/orange solid precipitated on the addition of pentane. The solid was isolated by filtration and redissolved in minimum dichloromethane and precipitated with pentane and isolated by filtration a further three times. The solvent was then removed by cannula filtration and the solid dried under vacuum. Yield = 150 mg (66 %). 1H NMR (CD2C12, 400 MHz, 295 K): δ 4.74 (s, 5H, Hi), 6.80 - 6.84 (m, 2H, H5), 6.84 - 6.92
(m, 12H, Hio/n), 7.23 -7.31 (td, 3JHH = 7.8 Hz, 4JHH = 1.6 Hz, 12H, H10/n), 7.31 - 7.37 (m,
2H, H6), 7.42 (tt, VHH = 7.6 Hz, 4JHH = 1.9 Hz, 1H, H7), 7.48 (t, 3JHH = 7.8 Hz, 6H, H12)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 95.8 (s, Ci), 122.1 (q, ¥ = 272.7 Hz, C8), 123.3 (s,
C4), 126.3 (q, 2JCF = 34.8 Hz, C3), 128.7 (t, J = 10.6 Hz, Cio/11), 129.4 (s, C6), 129.8 (s, C7),
131.4 (s, C5), 131.5 (s, C12), 133.2 - 132.4 (m, C9), 133.6 (app. t, sum of JCP = 10.6 Hz,
Cio/11), 340.0 (tq, 2JCP = 15.2 Hz, 3JCF = 3.3 Hz, C2)
19F NMR (CD2CI2, 471 MHz, 295 K): δ -57.6 (s, F8), -154.1 (BF4 ")
31P NMR (CD2CI2, 202 MHz, 295 K): δ 39.6 (s, PPh3)
ESI-MS (m/z): Expected for C5oH4oF3P2Ru = 861.1595; Observed: 861.1611 [M+H+] (Error = 1.6 mDa)
Elemental Analysis: C5oH4oBF7P2Ru Calc. /% C 63.37, H 4.25 Found /% C 63.07, H 4.26.
Example 34
Synthesis of [Ru2^-C4H2F)(ti5-C5H5)2(PPh3)4] [BF4], [13] [BF4]
Figure imgf000074_0001
A mixture of Ru(C≡CH)^5-C5H5)(PPh3)2 [Id] (50 mg, 0.07 mmol) and l-fluoro-2,4,6,- trimethylpyridinium tetrafluoroborate (10 mg, 0.04 mmol) dissolved in dichloromethane (10 mL), was stirred at room temperature for 30 minutes. The resultant orange-brown solution was reduced to a minimum volume, and the orange-brown solid precipitated out with diethyl ether (25 mL). The orange-brown precipitate was washed further with diethyl ether (4 x 25 mL), filtered, and dried in vacuo to give an orange solid. Yield = 36 mg (37 %).
1H NMR (500 MHz, CD2C12): δ 4.37 (s, 10H, Hi), 4.84 (d, 2JHF = 57.6 Hz, 1H, H2), 7.13 (m, 60 H, 12 x Ph), 7.45 (d, 4JHF = 12.5 Hz, 1H, H3)
Selected 13C NMR (126 MHz, CD2C12): δ 89.4 (s, C5H5, Ci), 108.7 (d, 2JCF = 233.1 Hz, C2), 183.2 (d, 4JCF = 25.1 Hz, C3), 250.6 (dt, 3JCF = 20.1 Hz, 3JCP= 13.5 Hz, C4)
19F NMR (471 MHz, CD2C12): δ -152.9 (BF4 "), -138.7 (dd, 2JHF = 57.6 Hz, 4JHF = 12.5 Hz, F2) ESI-MS (m/z): Expected for C86H72FP4Ru2 = 1451.2650; Observed = 1451.2703 [M+] (Error = 5.3 mDa)
Example 35
Synthesis of [Ru^5-C5H5)(PPh3)(-C6H4-PPh2-^2-CH=CFPh})] [BF4], [14] [BF4]
Figure imgf000075_0001
A Young's NMR tube was charged with [Ru(n5-C5H5)(PPh3)2(=C=CPhF)][BF4], [2a][BF4] (20 mg, 0.02 mmol) in d3-acetonitrile (0.5 mL), and heated at 50 °C for around 2 weeks.
Selected 1H NMR (CD3CN, 500 MHz, 295 K): δ 4.69 (ddd, 3JHF = 16.9 Hz, 2JPH = 5.0 Hz, 3JPH = 1.7 Hz, 1H, H8), 4.95 (s, 5H, ¾) Selected 13C NMR (CD3CN, 125 MHz, 295 K): δ 25.9 (ddd, 1JCP = 75.1 Hz, 2JCF = 7.8 Hz, 2JCP = 2.7 Hz, C8), 92.7 (s, Ci), 113.7 (dt, ^CF = 243.0 Hz, 2JCP = 5.6 Hz, C9), 170.9 (dd, 2JCP = 32.6 Hz, 2JCp = 16.6 Hz, C2)
19F NMR (CD3CN, 471 MHz, 295 K): δ -153.0 (BF4 "), -143.4 (app. dt, 3JPF = 48.6 Hz, 3JHF = 16.9 Hz, 3JpF = 16.2 Hz, F9)
31P NMR (CD3CN, 202 MHz, 295 K): δ 42.3 (dd, 3JPF = 16.2 Hz, 3JPP = 4.4 Hz), 46.6 (dd, 3JPF = 48.6 Hz, 3JPP = 4.4 Hz)
ESI-MS (m/z): Expected for C49H40FP2RU = 811.1627; Observed: 811.1637 (Error = 1.0 mDa)
Example 36
Synthesis of [Ru( 5-C5H5)(PPh3)2(-C(NC5H5)=C(C6H5)F)] [BF4], [15][BF4]
Figure imgf000076_0001
An oven-dried ampoule was charged with [Ru^5-C5H5)(PPh3)2(=C=CPhF)][BF4], [2a] [BF4] (65 mg, 7.2 μmol) and pyridine (1 mL), and left to stir for 20 minutes. The reaction mixture was then added via a syringe to rapidly stirring diethyl ether (15 mL), to precipitate an orange powder. The solid was isolated by cannula filtration and dried under vacuum. Yield = 40 mg
(57 %). 1H NMR (CD2C12, 700 MHz, 275 K): δ 4.16 (s, 5H, Hi), 6.32 (d, 3JHH = 7.6 Hz, 2H, ¾), 6.97 (apparent t, 3JHH = 7.6 Hz, 2H, H9), 7.02 (t, 3JHH = 7.6 Hz, 1H, Hi0), 7.19 (apparent t, 3JHH = 7.4 Hz, 12H, H13), 7.27 (t, 3JHH = 7.4 Hz, 12H, H12), 7.39 (t, 3JHH = 7.4 Hz, 6H, H14), 7.61 (apparent t, 3JHH = 7.0 Hz, 2H, H4), 8.07 (t, 3JHH = 7.9 Hz, 1H, H5), 8.27 (d, 3JHH = 5.8 Hz, 2H, H3)
13C NMR (CD2CI2, 176 MHz, 275 K): δ 84.9 (s, Ci), 127.2 (s, C4), 127.8 (s, C8/9), 128.1 (t, sum of Jcp = 8.6 Hz, C12/13), 128.6 (s, Cio), 128.7 (s, C8/9), 129.8 (s, CM), 132.3 (d, 2JCF = 32.8 Hz, C7), 134.1 (t, sum of JCP = 8.6 Hz, Cuns), 138.5 (t, \½ + 3JCp = 39.7 Hz, CN), 142.6 (s, C5), 145.4 (s, C3), 149.6 (dt, 1JCF = 84.8, 3JCP = 17.0 Hz, C2), 164.5 (d, ^CF = 232.7 Hz, C6) . 19F NMR (CD2CI2, 471 MHz, 293 K): δ -152.3 (BF4 "), -71.1 (t, 4JPF = 20.1 Hz, F6)
31P NMR (CD2CI2, 202 MHz, 293 K): δ 44.0 (d, 4JPF = 20.3 Hz, PPh3)
ESI-MS (m/z): Expected for C54H45F P2Ru = 890.2049; Observed: 890.2039 [M+] (Error = 1.0 mDa).
Example 37
Synthesis of [Ru( 5-C5H5)(PPh3)((C5H4N)C(C5H5N)=C(C6H5))][BF4], [16] [BF4]
Figure imgf000077_0001
An oven-dried ampoule was charged with [Ru^5-C5H5)(PPh3)2(=C=CPhF)][BF4], [2a] [BF4] (65 mg, 7.2 μmol) and pyridine (1 mL), and left to stir for 3 days. The reaction mixture was then layered with pentane. The crystals were isolated by cannula filtration and dried under vacuum.
1H NMR (CD2C12, 500 MHz, 295 K): δ 4.80 (s, 5H, Hi), 6.48 (d, 3JHH = 6.2 Hz, 1H, H8/8>), 6.64 (dd, 3JHH = 8.2 Hz, 4JHH = 1.1 Hz, 2H, ¾3), 6.79 - 6.88 (m, 2H, H4, ¾), 6.99 (tt, 3JHH = 7.4 Hz, 4JHH = 1.3 Hz, 1/2H, H14/15), 7.08 (t, 3JHH = 7.4 Hz, 2/3/4H, Hi4/15> H19) 7.27 (br m, 6/7H, PPh3), 7.39 (m, 6H, PPh3, H3), 7.66 (m, 1H, H9/9>), 7.93 (m, 1H, Η9/9·), 8.22 (d, 3JHH = 8.1 Hz, H6), 8.33 - 8.39 (m, 2H, H8/8>, ¾<>)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 85.1 (s, Ci), 115.3 (s, C5), 124.8 (s, C13), 125.5 (s, Cis), 126.2 (s, C4), 128.2 (s, CM), 128.3 (s, PPh3), 128.5 (s, C9/9 , 129.2 (s, C9/9 , 12 .9 (s, PPh3), 133.7 (br, PPh3), 134.2 (s, C3), 136.8 (d, 2JCP = 42.2 Hz, C16), 144.1 (s, C6), 146.1 (s, C8/8 , 146.4 (s, C8/8 , 146.8 (s, C10), 150.5 (s, C12), 199.1 (br, Cn), 218.0 (br, C2)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 60.0 (br, PPh3).
ESI-MS (m/z): Expected for Q1H25D9N2PRU = 696.2063; Observed: 696.2084 [M+] (Error = 2.1 mDa)
Example 38
Synthesis of ] [BF4]
Figure imgf000078_0001
Prepared as described in the literature. Example 39
Synthesis of F4]
Figure imgf000079_0001
An oven-dried Schlenk tube was charged with [Ru(rj5-C5H5)(PPh3)2(-C≡CPh)] [la] (50 mg, 0.063 mmol) in CH2CI2 (10 mL). To this solution was added sodium tetrafluoroborate (6.93 mg, 0.063 mmol) followed by N-chlorosuccinimide (8.45 mg, 0.063 mmol), resulting in a colour change from orange to bright green. After stirring for 1 minute the solution was transferred by cannula filtration to another oven-dried Schlenk tube, and the solvent was removed under vacuum. The residue was washed three times with diethyl ether and dried under vacuum leaving the green solid product. Yield = 8 mg (14 %).
1H NMR (CD2CI2, 700 MHz, 295 K): δ 5.31 (s, 5H, Hi), 6.97 (t, 3JHH = 8.9 Hz, 12H, H9/10), 7.10 (d, VHH = 7.5 Hz, 4H, H5), 7.25 (t, 3JHH = 7.3 Hz, 12H, H9/10), 7.31 (t, 3JHH = 7.5 Hz, 3H, H6/7), 7.43 (t, 3JHH = 7.3 Hz, 6H, Hn), 7.46 (t, 3JHH = 7.5 Hz, 3H, ¾/7)
13C NMR (CD2CI2, 176 MHz, 295 K): δ 95.9 (s, Ci), 127.3 (s, C3/4), 128.1 (s, C5), 128.8 (app. t, sum ofJCP = 10.4 Hz, C9/10), 129.0 (s, C6/7), 131.3 (s, Cn), 133.0-133.3 (m, 1JCP + 3JCP = 52.3 Hz, C8), 133.5 (app. t, sum of JCP = 10.3 Hz, C9/10), 133.6 (s, C6/7), 139.4 (s, C3/4), 353.5 (t, C2)
ESI-MS (m/z): Expected for C49H40ClP2Ru = 827.1332; Observed: 827.1306 [M+] (Error = 2.6 mDa) Example 40
Synthesis of F4]
Figure imgf000080_0001
An oven-dried Schlenk tube was charged with [Ru(rj5-C5H5)(PPh3)2(-C≡CPh)] [la] (50 mg, 0.063 mmol) in dichloromethane (10 mL). To this solution was added sodium tetrafluoroborate (6.93 mg, 0.063 mmol) followed by bromine (3.2
Figure imgf000080_0002
0.063 mmol), resulting in a colour change to bright green. After stirring for 1 minute the solution was transferred by cannula filtration into excess pentane producing a green precipitate. The solvent was removed by cannula filtration and the remaining green solid dried under vacuum. This was then extracted with the minimum amount of dichloromethane and recrystallized in excess pentane. The solvent was then removed by cannula filtration and the green solid product dried under vacuum. Yield = 14 mg (23 %).
1H NMR (CD2C12), 500 MHz, 295 K): δ 5.29 (s, 5H, Hi), 6.98 (d, 3JHH = 7.8 Hz, 12H, H9), 7.05 (d, 3JHH = 7.7 Hz, 2H, He), 7.09 (d, 3JHH = 7.7 Hz, 2H, ¾), 7.27 (t, 3JHH = 7.8 Hz, 12H, H10), 7.30 (t, 3JHH = 7.1 Hz, 1H, H7), 7.45 (t, 3JHH = 7.2 Hz, 6H, Hn)
13C NMR (CD2CI2, 125 MHz, 295 K): δ 95.7 (s, Ci), 123.7 (s, C3/4), 127.6 (s, C3/4), 128.8 (app. t, sum ofJCP, = 10.6 Hz, C9/10), 129.2 (s, C5/6/7), 129.3 (s, C5/6/7), 129.4 (s, C5/6/7), 131.3 (s, C11), 133.0-133.4 (app. t, ^cp and 3JCP = 51.8 Hz, C8), 133.6 (app. t, sum ofJCP = 5.3 Hz, C9/10), 340.3 (t,2JCP = 16.0 Hz, C2) 31P NMR (CD2C12, 202 MHz, 295 K): δ 41.2 (s, PPh3)
ESI-MS (m/z): Expected for C49H4oBrP2Ru = 871.0827; Observed: 871.0835 [M+] (Error = 0.8 mDa).
Example 41
Synthesis of [Ru(q5-C5H5)(PPh3)2(=C=CBrC6H4-4-Br)] [Br3], [17d][Br3]
Figure imgf000081_0001
An oven-dried Schlenk tube was charged with [Ru(rj5-C5H5)(PPh3)2(-C≡CPh)] [la] (100 mg, 0.126 mmol) in tetrahydrofuran (10 mL). Bromine (100
Figure imgf000081_0002
1.89 mmol) was added resulting in a colour change from orange to green. After 15 minutes stirring the solvent was removed by vacuum leaving a green solid. This was extracted with the minimum amount of dichloromethane and recrystallized in excess diethyl ether. The solvent was then removed by cannula filtration and the dark green crystals dried under vacuum. Yield = 47 mg (72 %).
1H NMR (CD2C12, 500 MHz, 295 K): δ 5.30 (s, 5H, Hi), 6.93 (d, 3JHH = 7.9 Hz, 2H, H6), 6.97 (m, 12H, H9), 7.27 (t, 3JHH = 6.9 Hz, 12H, ¾0), 7.39 (d, 3JHH = 7.7 Hz, 2H, H5), 7.47 (t, 3JHH = 6.9 Hz, 6H, Hn).
13C NMR (CD2C12, 125 MHz, 295 K): δ 96.1 (s, Ci), 123.1 (s, C3/7), 123.2 (s, C3/7), 126.8 (s, C4), 128.9 (app. t, sum of JCP, = 10.6 Hz, C9/10), 130.7 (s, C5/6), 131.4 (s, Cn), 132.3 (s, C5/6), 133.1 (app. t, ^ΟΡ + 3JCP = 51.8 Hz, C8), 133.6 (app. t, sum of JCP = 10.6 Hz, C9/10), 339.3
Figure imgf000082_0001
31P NMR (CD2C12, 202 MHz, 295 K): δ 40.9 (s, PPh3)
ESI-MS (m/z): Expected for C49H39Br2P2Ru = 950.9928; Observed: 950.9910 [M+] (Error = 1.8 mDa)
Example 42
Synthesis of [Ru(ti5-C5H5)(PPh3)2(=C=CIPh)] [I3], [17e] [I3]
Figure imgf000082_0002
An oven-dried Schlenk tube was charged with [Ru^5-C5H5)(PPh3)2(-C≡CPh)] [la] (100 mg, 0.126 mmol) in dichloromethane (10 mL) . Iodine (85 mg, 0.335 mmol) was added resulting in an immediate colour change from orange to dark green. After stirring for 20 minutes the solvent was removed under vacuum leaving a dark green solid.
The dark green solid was extracted with the minimum amount of dichloromethane and recrystallized in excess diethyl ether. The solvent was then removed by cannula filtration and the dark green crystals dried under vacuum. Yield = 37 mg (29 %).
1H NMR (CD2CI2, 500 MHz, 295 K): δ 5.23 (s, 5H, Hi), 6.96-7.03 (m, 12H, ar), 7.23-7.31 (m, 17H, ar), 7.43-7.50 (m, 6H, ar) 1JC NMR (CD2C12, 125 MHz, 295 K): δ 95.2 (s, Ci), 128.8 (app. t, sum of JCP, = 10.5 Hz, C9/10), 129.0 (s, C7), 129.1 (s, C3/4), 129.3 (s, C5/6), 130.1 (s, C5/6), 131.3 (s, Cn), 133.0 (s, C3/4), 133.0 - 133.6 (m, C8), 133.7 (app. t, sum of JCP, = 10.6 Hz, C9/10), 323.6 (t, 2JCP = 16.0 Hz, C2)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 40.3 (s, PPh3)
ESI-MS (m/z): Expected for C49H40IP2RU = 919.0688; Observed: 919.0698 [M+] (Error = 1.0 mDa)
Example 43
Synthesis of [Ru(ti5-C5H5)(NCMe)(PPh3)2][PF6], [18][PF6]
Figure imgf000083_0001
34
Prepared as described in the literature.
Example 44
Synthesis of [Ru(ti5-C5H5)(PPh3)(Pyr)2] [PF6], [19] [PF6]
Figure imgf000083_0002
31
Prepared as described in the literature. Example 45
Synthesis of (E)-[Ru( 5-C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})] [PF6], [20] [PF6]
Figure imgf000084_0001
Prepared as described in the literature.31
Example 46
Synthesis of [Ru( 5-C5H5)(PPh3)(C5H4NCF2C{C6H4-4-CF3})] [BF4], [21] [BF4]
Figure imgf000084_0002
An NMR tube with a PTFE J. Young's tap was charged with [Ru(n5- C5H5)(pPh3XC5¾NCHC{C6H4-4-CF3 })], [9], (20 mg, 30 μιηοΐ) and l-fluoro-2,4,6- trimethylpyridinium tetrafluoroborate (13.6 mg, 60 μιηοΐ) in CD2CI2 (0.5 mL). On addition of l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate, an immediate colour change was observed from brown to green. The reaction mixture was allowed to stand for 24 hours, and monitored by NMR spectroscopy.
On complete conversion, the reaction mixture was transferred to a Schlenk tube, and an excess of pentane was added via a cannula transfer to produce a green precipitate. This residue was washed with further pentane (2 x 10 mL) by cannula filtration, and dried under vacuum to yield a dark green precipitate. Isolated yield = 9 mg (38 %).
1H NMR (CD2C12, 500 MHz, 295 K): δ 5.35 (s, 5H, Hi), 7.07 (app. td, 3JHH = 6.9 Hz, 4JHH =
1.1 Hz, 1H, H9), 7.12 - 7.19 (dd, 3JHH = 8.2 Hz, 3JHp = 11.9 Hz, 6H, ¾/¾), 7.39 (d, 3JHH =
8.2 Hz, 2H, H14), 7.43 (app. td, 3JHH = 7.8 Hz, 4JHp = 2.6 Hz, H3/H4, ¾), 7.46 - 7.55 (m, 5H, H5, His), 8.09 (d, 3JHH = 8.4 Hz, 1H, H7), 8.14 (app. d, 3JHH = 6.7 Hz, 1H, ¾<>) Resonances due to 2,4,6-trimethylpyridinium tetrafluoroborate([HTMP][BF4]), which could not be removed from this sample by recrystallisation, have been omitted. Integrations are not shown where the [HTMP][BF4] and [21] [BF4] resonances overlap.
13C NMR (CD2CI2, 125 MHz, 295 K): 93.0 (s, Ci), 123.5* (C17) 131.5* (Ci6), 120.9 (s, C9), 125.8 (s, Ci4), 129.6 (d, JCP = 10.7 Hz, C3/4), 131.3 (d, 2JCP = 51.5 Hz, C2), 132.1 (s, C5), 132.3* (C11), 133.4 (d, JCP = 11.1 Hz, C3/4), 137.6 (s, C10), 144.0 (s, C7), 207.6* (C6), 284.5* (C12) (* = resonances located by : : 1 "( ' ; two-dimensional correlation spectra).
19F NMR (CD2CI2, 471 MHz, 295 K): δ -153.0 (BF4 "), -98.3 (d, 2JFF = 233.1 Hz, Fn), -79.7
(dd, 2JFF = 233.1 Hz, 4JPF = 6.6 Hz, Fn), -66.4 (s, Cn)
31P NMR (CD2CI2, 202 MHz, 295 K): δ 47.2 (d, 4JPF = 6.6 Hz, PPh3)
Attempts to locate C8, Ci3 and C15 using a range of NMR techniques were unsuccessful. ESI-MS (m/z): Expected for C37H28F5NP101 9Ru = 714.0918; Observed: 714.0920 [M+]
(Error = 0.2 mDa)
Elemental Analysis: C37H28BF9NPRu + 1 C8Hi2BF4N ([HTMP][BF4]) Calc. /% C 53.54, H 3.99, N 2.75. Found /% C 53.814, H 4.227, N 3.062. Complex [21][BF4] could not be isolated cleanly without one equivalent of [HTMP][BF4], which is formed during the deprotio-difluorination of metallocycle [9], as both [21][BF4] and [HTMP][BF ] crystallise under identical conditions.
Example 47
Preparation of [Ru^5-C5H5)(PPh3)(C5H4NCFC{C6H4-4-CF3})], [22]
Figure imgf000086_0001
An NMR tube with a PTFE J. Young's tap was charged with [Ru(n5- C5H5)(PPh3)(C5H4NCF2C{C6H4-4-CF3})][BF4], [21][BF4], (6 mg) dissolved in pyridine-d5 (0.5 mL). The reaction was monitored over 7 days, and produced a mixture of [Ru(n5- C5H5)(PPh3)(C5H4NCFC{C6H4-4-CF3 })], [22], and the oxygen-containing complex, [24][BF ]. [22] can also be made independently from the dissolution of [10][BF ] in pyridine. Dissolution in d5-pyndine allows full NMR characterisation to be recorded.
Characterisation of [Ru^5-C5H5)(PPh3)(C5H4NCFC{C6H4-4-CF3})], [22]
1H NMR (NC5D5, 500 MHz, 295 K): 4.95 (s, 5H, Hi), 6.58 (td, 3JHH = 6.7 Hz, 4JHH = 1.2 Hz, 1H, H9), 6.68 (m, 1H, ¾), 7.21 - 7.26 (m, 6H, H3/4), 7.26 - 7.36 (m, 9H, H3/4, H5), 7.45 - 7.49 (m, 2H, ¾4), 7.54 - 7.59 (m, 2H, ¾5), 7.71 (d, 3JHH = 6.4 Hz, H7), 8.29 (d, 3JHH = 8.1
13C NMR (NC5D5, 125 MHz, 295 K): 83.9 (s, Ci), 113.8 (s, C9), 124.9 (q, 3JCF = 3.8 Hz, Cis), 126.1 (q, lJCF = 271.6 Hz, C17), 126.3 (s, C8), 126.4 (q, 2JCF = 31.8 Hz, Ci6), 128.4 (d, JCP = 9.4 Hz, C3/4), 129.8 (s, C5), 129.8 (s, CM), 133.9 (d, JCP = 10.8 Hz, C3/4), 134.8 (s, C7), 137.2 (d, 1JCp = 41.4 Hz, C2), 143.2 (s, C10), 146.9 (br, C12), 153.9 (br, Ci3), 215.1 (br, C6) 19F NMR (NC5D5, 376 MHz, 295 K): -111.7 (s, Fn), -63.5 (s, Fn)
31P NMR (NC5D5, 202 MHz, 295 K): 61.5 (s, PPh3)
ESI-MS (m/z): Expected for C37H28F4 P101'9Ru = 695.0939; Observed: 695.0961 [M+] (Error = 2.2 mDa)
Example 48
Characterisation of oxygen containing complex, [24] [BF4]
Figure imgf000087_0001
Selected 1H NMR (NC5D5, 500 MHz, 295 K): δ 5.09 (s, ¾)
19F NMR (NC5D5, 471 MHz, 295 K): δ -153.0 (BF4 "), -78.7 (d, 2JFF = 208.5 Hz, CF2), -67.6
(d, 2JFF = 208.5 Hz, CF2), -64.5 (s, CF3)
31P NMR (NC5D5, 202 MHz, 295 K): δ 43.2 (s, PPh3)
ESI-MS (m/z): Expected for C37H28F5NOP101 9Ru = 730.0872; Observed: 730.0872 [M+] (Error <0.05 mDa)
ATR IR (v /cm"1): 528.1 (m), 697.6 (m), 1066.2 (s, C-F stretch), 1090.1 (s, C-F stretch), 1206.5 (m), 1324.4 (m), 1413.0 (w, C=C stretch), 1436.4 (w, C=C stretch), 1458.3 (w, C=C stretch), 1481.1 (w, C=C stretch), 1540.4 (w, C=C stretch), 1640.1 (m, C=0 stretch), 2991.0 (w, C-H stretch), 3124.5 (w, C-H stretch), 3184.5 (w, C-H stretch), 3303.9 (w, C-H stretch) Example 49
Synthesis of [fra«s-Ru(dppm)2Cl(-C≡C-Ph)], [31]
Figure imgf000088_0001
Prepared as described in the literature.
(D. Touchard, P. Haquette, N. Pirio, L. Toupet and P. H. Dixneuf, Organometallics, 1993, 12, 3132-3139.)
Example 50
Synthesis of [ira«s-Ru(dppm)2Cl(=C=CFPh)] [BF4], [32] [BF4]
Figure imgf000088_0002
An oven dried Schlenk tube was charged with [tra«s-Ru(dppm)2Cl(-C≡C-Ph)], [39] (50 mg, 0.07 mmol) dissolved in DCM (ca. 5 mL); separately a solution of Selectfluor (22.7 mg, 0.08 mmol) in acetonitrile (ca. 5 mL) was prepared and transferred via cannula into the ruthenium solution. The solvent was stirred for 10 minutes before being filtered and the solvent was removed in vacuo. The green solid was washed with pentane (2 x 5 mL) and dried in vacuo. Yield was not determined. 19F NMR (CD2C12, 376 MHz, 295 K): δ -221.8 (bs, F3)
31P NMR (CD2C12, 202 MHz, 295 K): δ -13.6 (s, dppm)
ESI-MS (m/z): Expected for C58H49CIFP4RU = 1025.1507 m/z; Observed: 1025.1544 m/z [M+] (Error = -3.7 mDa)
Low temperature NMR study of the monofluorination reaction, [9] to [10][BF4]
An NMR tube with a PTFE J. Young's tap was charged with [Ru(n5- C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})], [9], (20 mg, 30 μιηοΐ) and CD2C12 (0.5 mL). 1H, 19F and 31P NMR spectra were recorded. The NMR tube was then cooled in a dry ice/acetone bath and l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate (6.7 mg, 30 μιηοΐ) added. The NMR spectra were then recorded at a range of temperatures from 195 K to 295 K.
No evidence of any reaction intermediates was observed.
31P NMR
After the addition of l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate (F+), the initial spectra were recorded at 195 K, and evidence for the mono-fluorinated metallocycle
[10][BF4] was obtained at this temperature (31P NMR: δ 47.7, br). The integration of this resonance did not increase, relative to [Ru^5-C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})], [9], on warming the sample to 245 K. This suggests that the initial fluorination occurred on transferring the sample into the NMR spectrometer, during which time it may not have remained at low temperature. However, by 265 K, the signal for [Ru(n5- C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})], [9], could no longer be observed, and the dominant species in the reaction mixture was [10][BF4].
During the experiment, as the temperature was increased, the signal for [Ru(n5- C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})], [9], at around δ 62 ppm became broader. This could be due to reversible protonation and deprotonation with the solvent, as has been described previously. A small resonance was also observed at around δ 30.1 ppm, attributed to triphenylphosphine oxide. iyF NMR
Before the addition of F+, one resonance was observed at δ -63.3 ppm due to the CF3 moiety of [Ru^5-C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})], [9]. 19F NMR spectra were recorded from 245 K onwards. On the addition of F+, the monofluorinated product [10][BF4] could be observed at 245 K by the appearance of new resonances at δ 140.1 ppm (d, HF = 52.0 Hz) and an additional resonance in the -CF3 region. The resonance for F+ was also visible at δ 16.3 ppm (s) and -153.6 (BF "). Spectra recorded at 265 K showed the characteristic resonance for [10][BF4] was growing, and by 285 K, two small doublets were visible for the bisfluorinated product [21][BF4] (δ -96.6, d, 2JFF = 233.1 Hz and -78.0 dd, 2JFF = 233.1 Hz, 4JPF = 6.6 Hz).
Broadening of the resonance attributed to the -CF3 group of 2 was also observed with increasing temperature, in correlation with the broadening of the 31P NMR resonance associated with this complex. A small resonance was also observed at δ -220.1 ppm, 2JHF = 47.3 Hz. This has been attributed to 2-monofluoromethyl-4,6-dimethylpyridine formed by deactivation of the l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate.
1H NMR
On the addition of F+, 2 sets of resonances were observed for the methyl groups of 2,4,6- trimethylpyridine. These could be due to 2,4,6-TMP, l-fluoro-2,4,6-TMP or l-proteo-2,4,6- TMP. By 265 K, only one set of resonances were present, suggesting that all of the F+ had been delivered. The cyclop entadienyl resonance for the initial metallocycle [Ru(n5- C5H5)(PPh3)(C5H4NCHC{C6H4-4-CF3})], [9], was observed at δ 4.79 ppm at 195 K, but broadened over time with increasing temperature as was observed in the 31P and 19F NMR spectra. By 265 K, this Cp resonance was no longer observed and the resonance for the mono-fluorinated [10] [BF4] species became dominant.
X-Ray Crystallography
Diffraction data was collected using an Oxford Diffraction SuperNova diffractometer equipped with a single Molybdenum source using Mo-Ka radiation (0,71073 A) and an EOS CCD camera. The crystals were cooled with an Oxford Instruments Cryojet typically to 11 OK. Diffractometer control, data collection, initial unit cell determination, frame integration and unit-cell refinement was carried out with "CrysalisPro". Face-indexed absorption corrections were applied either using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm or analytical numeric absorption correction using a multifaceted crystal model based on expressions derived by Clark and Reid, implemented within "CrysalisPro". OLEX2 was used for overall structure solution, refinement and preparation of computer graphics and publication data. Using 01ex2, the structure was solved either with the Superflip structure solution program using Charge Flipping or the ShelXS structure solution program using Direct Methods. Refinement was carried out with the ShelXL refinement package using Least Squares minimisation. All non-hydrogen atoms were refined anisotropically. Unless stated otherwise, hydrogen atoms were placed using a "riding model" and included in the refinement at calculated positions.
Special refinement details
e^5~C5H5)(PPh3)2(~C≡C-C6H4- -CF3)], [lb]. The CF3 group was disordered and modelled in two positions, with refined occupancy of 0.860:0.140(8). The carbon-fluorine and fluorine-fluorine bond distances were restrained to 1.32 A and 2.12 A respectively.
[Ru( 5-C5H5)(PPh3)2(=C=CFPh)], [2a][PF6], green form.
The dichloromethane of crystallization has a disordered chloride atom, which has been modelled in two positions with a refined occupancy ratio of 0.77:0.23(3).
[Ru(ti5-C5H5)(PPh3)2(=C=CFPh)], [2a][PF6], orange form.
The PF6 counter-ion was disordered (rotation about one F-P-F axis), and four fluorine atoms were modelled in two positions with occupancies of 0.957:0.043(3). The fluorine atoms of the minor component were restrained to be approximately isotropic and the distances between them were restrained to be equal. The ADP of opposite pairs of fluorine atoms in the minor component were constrained to be equivalent e.g. F4A and F6A.
[Ruto5-Cs¾)(PPh3)2(=C=CCF3Ph)]BF4, [12] [BF4],
The tetrafluoroborate anion was disordered, with three of the fluorines each modelled in two positions with refined occupancies of 0.903 :0,097(4). The dichloromethane of crystallisation was also disordered with one of the chlorines modelled in two positions with refined occupancies of 0.663 : 0.337(3 ) . [Ru( 5-C5H5)(PPh3)2(-C(NC5H5)=C(C6H5)F)] [BF4], [15] [BF4].
The BF4 was disordered and modelled in two positions. The occupancies were refined to 0.65:0.35 (4). The boron-fluorine bond lengths were restrained to 1.4 A and the fluorine- fluorine bond lengths were restrained to 2.285 A. Rii(i|5~C5Hs)(PPh3)2(-C5H4N~C{NC5H5)=C(C6H5)~)] [BF4], [16] [BF4].
The structure was non-merohedrally twinned and modelled using 2-components. The asymmetric unit contained two complex cations, two tetrafluoroborate anions and a pyridine of crystallisation.
Structure of Ru^5-C5H5)(PPh3)2(-C C-C6H4-4-CF3) [lb] is illustrated in Figure
Identification code [lb]
Empirical formula C50H39F3P2RU
Formula weight 859.82
Temperature 110.00(14) K
Crystal system monoclinic
Space group P2i/c
a 16.8756(3) A
b 15.1925(2) A
c 17.3468(4) A
a 90°
β 116.921(3)°
Y 90°
Volume 3965.46(16) A3
Z 4
Calculated Density 1.440 mg/mm3
Absorption Coefficient 0.526 mm"1
F(000) 1760.0
Crystal size 0.3086 0.1372 χ 0.1372 mm3
Radiation ΜοΚα (λ = 0.71071)
2Theta range for data collection 5.906 to 60.482°
Index ranges -23 < h < 21, -21 < k < 20, -24 < 1 < 23 Reflections collected 22877
Independent reflections 10476 [Rint = 0.0296, Rsigma = 0.0420] Data/restraints/parameters 10476/12/515
Goodness-of-fit on F2 1.052
Final R indexes [1>=2σ (I)] Ri = 0.0324, wR2 = 0.0724
Final R indexes [all data] Ri = 0.0437, wR2 = 0.0781
Largest diff peak and hole 0.52/-0.49 e A"3 Structure of [Ru(q5-C5H5)(PPh3)2( C=CFPh)] [PF6] [2a] [PF6] green form is illustrated in Figure 1(a)
Identification code [2a] [PF6] green form
Empirical formula C50H42CI2F7P3RU
Formula weight 1040.71
Temperature 110.05(10) K
Crystal system orthorhombic
Space group Pbca
a 17.3578(2) A
b 14.44250(18) A
c 36.1516(4) A
a 90°
β 90°
Y 90°
Volume 9062.86(19) A3
Z 8
Calculated Density 1.525 mg/mm3
Absorption Coefficient 0.634 mm"1
F(000) 4224.0
Crystal size 0.3612 0.0695 χ 0.0598 mm3
Radiation ΜοΚα (λ = 0.71073)
2Theta range for data collection 5.586 to 60.844°
Index ranges -24 < h < 22, -20 < k < 20, -48 < 1 < 51
Reflections collected 85888
Independent reflections 12862 [Rint = 0.0323, Rsigma = 0.0220]
Data/restraints/parameters 12862/1/578
Goodness-of-fit on F2 1.066
Final R indexes [1>=2σ (I)] Ri = 0.0267, wR2 = 0.0601
Final R indexes [all data] Ri = 0.0320, wR2 = 0.0628
Largest diff peak and hole 0.40/-0.49 e A"3 Structure of
Figure imgf000097_0001
[2a] [PF6] orange form is illustrated in Figure 1(b)
Identification code [2a] [PF6] - orange form
Empirical formula C50H42.12CI2F6.88P3RU
Formula weight 1038.64
Temperature 110.05(10)
Crystal system orthorhombic
Space group Pbca
a 17.5524(3)
b 19.8953(4)
c 25.3282(5)
a 90
β 90
Y 90
Volume 8844.9(3)
Z 8
Calculated Density 1.560
Absorption Coefficient 0.650
F(000) 4216.6
Crystal size 0.3926 0.2659 χ 0.1639
Radiation ΜοΚα (λ = 0.71073)
2Θ range for data collection 5.702 to 64.422
Index ranges -19 < h < 25, -28 < k < 24, -28 < 1 < Reflections collected 33223
Independent reflections 14037 [Rint = 0.0297, Rsigma = 0.0380] Data/restraints/parameters 14037/30/604
Goodness-of-fit on F2 1.049
Final R indexes [1>=2σ (I)] Ri = 0.0318, wR2 = 0.0730
Final R indexes [all data] Ri = 0.0444, wR2 = 0.0806
Largest diff peak and hole 0.62/-0.57 Structure of [Ru -C5H5)(PPh3)(C5H4NCFHC{C6H4-4-CF3})] [BF4], [10] [BF4] is illustrated in Figure 8
Identification code [10] [BF4]
Empirical formula C37H29BF8 PRu
Formula weight 782.46
Temperature 110.05(10) K
Crystal system monoclinic
Space group P2i
a 9.34095(17) A
b 17.7554(3) A
c 9.85967(18) A
a 90.00 °
β 102.9459(18) °
Y 90.00 °
Volume 1593.68(5) A3
Z 2
Calculated Density 1.631 mg/mm3
Absorption Coefficient 0.619 mm"1
F(000) 788.0
Crystal size 0.1405 0.064 χ 0.054 mm3
Radiation ΜοΚα (λ = 0.7107)
2Θ range for data collection 5.9 to 64.66°
Index ranges -13 < h < 13, -25 < k < 26, -14 < 1 < Reflections collected 20566
Independent reflections 10120 [Rint = 0.0313, Rsigma = 0.0467] Data/restraints/parameters 10120/1/446
Goodness-of-fit on F2 1.035
Final R indexes [1>=2σ (I)] Ri = 0.0291, wR2 = 0.0588
Final R indexes [all data] Ri = 0.0322, wR2 = 0.0606
Largest diff peak and hole 0.52/-0.45 e A"3
Flack parameter -0.028(14) Structure of [Ru(ti5-C5H5)(PPh3)2(=C=CCF3Ph)] [BF4] [12] [BF4] is illustrated in Figure 7
Identification code [12] [BF4]
Empirical formula C5iH42BCl2F7P2Ru
Formula weight 1032.56
Temperature 110.05(10) K
Crystal system orthorhombic
Space group Pbca
a 17.8473(4) A
b 14.6795(3) A
c 35.2252(16) A
a 90°
β 90°
Y 90°
Volume 9228.6(5) A3
Z 8
Calculated Density 1.486 mg/mm3
Absorption Coefficient 0.589 mm"1
F(000) 4192.0
Crystal size 0.2616 0.1943 x 0.1582 mm3
Radiation ΜοΚα (λ = 0.71073)
2Θ range for data collection 5.822 to 60.072°
Index ranges -25 < h < 20, -20 < k < 12, -36 < 1 < 49 Reflections collected 28548
Independent reflections 13431 [Rint = 0.0322, Rsigma = 0.0537] Data/restraints/parameters 13431/0/597
Goodness-of-fit on F2 1.107
Final R indexes [1>=2σ (I)] Ri = 0.0471, wR2 = 0.0826
Final R indexes [all data] Ri = 0.0631, wR2 = 0.0896
Largest diff peak and hole 1.14/-1.02 e A"3 Structure of [Ru -C5H5)(PPh3)2(-C(NC5H5)=C(C6H5)F)][BF4] [15] [BF4] is illustrated in Figure 11(b)
Identification code [15][BF4]
Empirical formula C54H45BF5 P2RU
Formula weight 976.73
Temperature 109.8(6) K
Crystal system triclinic
Space group P-l
a 11.6304(5) A
b 13.5851(7) A
c 15.1453(9) A
a 72.589(5)°
β 89.929(4)°
y 79.010(4)°
Volume 2237.5(2) A3
Z 2
Calculated density 1.450 mg/mm3
Absorption Coefficient 0.482 mm"1
F(000) 1000.0
Crystal size 0.1731 0.1338 χ 0.0366 mm3
Radiation ΜοΚα (λ = 0.71071)
2Theta range for data collection 6.166 to 63.606°
Index ranges -13 < h < 16, -20 < k < 14, -21 < 1 < 18
Reflections collected 20403
Independent reflections 13479 [Rint = 0.0280, Rsigma = 0.0514]
Data/restraints/parameters 13479/20/614
Goodness-of-fit on F2 1.033
Final R indexes [1>=2σ (I)] Ri = 0.0355, wR2 = 0.0769
Final R indexes [all data] Ri = 0.0474, wR2 = 0.0829
Largest diff peak and hole 0.63/-0.43 e A"3 Structure of Rufo -C3Hs)(PP 3)2{-C5H4 -C( CsHs)==C{C6H5)-) [16] [BF4] is illustrated in Figure 11(c)
Identification code [16][BF4]
Empirical formula C43 5H36 5BF4N2 5PRU
Formula weight 813.10
Temperature 110.05(10) K
Crystal system triclinic
Space group P-l
a 9.6081(8) A
b 17.9440(7) A
c 21.3274(10) A
a 99.508(4) 0
β 101.789(6) °
y 90.366(5) 0
Volume 3547.0(4) A3
Z 4
Calculated Density 1.523 mg/mm3
Absorption Coefficient 0.545 mm"1
F(000) 1660.0
Crystal size 0.4117 0.2117 x 0.0261 mm3
Radiation ΜοΚα (λ = 0.71073)
2Θ range for data collection 5.83 to 56.652°
Index ranges -12 < h < 10, -23 < k < 23, -28 < 1 < 27
Reflections collected 16538
Independent reflections 16538 [Rsigma = 0.0777]
Data/restraints/parameters 16538/636/956
Goodness-of-fit on F2 0.951
Final R indexes [1>=2σ (I)] Ri = 0.0560, wR2 = 0.1396
Final R indexes [all data] Ri = 0.0922, wR2 = 0.1545
Largest diff peak and hole 1.34/-2.03 e A"3 Structure of [Ru -C5H5)(PPh3)(C5H4NCF2C{C6H4-4-CF3})] [BF4] [21][BF4] is illustrated in Figure 9
Identification code [21] [BF4]
Empirical formula C37H28BF9 PRU
Formula weight 800.45
Temperature 110.05(10) K
Crystal system monoclinic
Space group Cc
a 14.5269(2) A
b 12.30582(14) A
c 19.9237(3) A
a 90.00°
β 113.8435(17)°
Y 90.00°
Volume 3257.69(8) A3
Z 4
Calculated Density 1.632 mg/mm3
Absorption Coefficient 0.612 mm"1
F(000) 1608.0
Crystal size 0.2484 0.1618 x 0.0793 mm3
Radiation Mo Κα (λ = 0.7107)
2Θ range for data collection 5.56 to 57.6°
Index ranges -19 < h < 16, -15 < k < 15, -24 < 1 < 26 Reflections collected 12746
Independent reflections 6049[R(int) = 0.0255]
Data/restraints/parameters 6049/2/451
Goodness-of-fit on F2 1.045
Final R indexes [1>=2σ (I)] Ri = 0.0247, wR2 = 0.0497
Final R indexes [all data] Ri = 0.0261, wR2 = 0.0510
Largest diff peak and hole 0.29/-0.28 e A"3
Flack parameter 0.001(15) References
1. T. Liang, C. N. Neumann and T. Patter, Angew. Chem., Int. Ed., 2013, 52, 8214-8264.
2. J. Wu, Tetrahedron Lett, 2014, 55, 4289-4294.
3. M. G. Braun and A. G. Doyle, J. Am. Chem. Soc, 2013, 135, 12990-12993.
4. M. G. Braun, M. H. Katcher and A. G. Doyle, Chem. Sci., 2013, 4, 1216-1220.
5. H. Dang, M. Mailig and G. Lalic, Angew. Chem., Int. Ed., 2014, 53, 6473-6476.
6. X. Y. Huang, W. Liu, H. Ren, R. Neelamegam, J. M. Hooker and J. T. Groves, J. Am. Chem. Soc, 2014,
136, 6842-6845.
7. N. Ichiishi, A. J. Canty, B. F. Yates and M. S. Sanford, Org. Lett , 2013, 15, 5134-5137.
8. H. G. Lee, P. J. Milner and S. L. Buchwald, J. Am. Chem. Soc, 2014, 136, 3792-3795.
9. W. Liu and J. T. Groves, Angew. Chem., Int. Ed, 2013, 52, 6024-6027.
10. A. R. Mazzotti, M. G. Campbell, P. P. Tang, J. M. Murphy and T. Ritter, J. Am. Chem. Soc, 2013, 135,
14012-14015.
11. T. Truong, K. Klimovica and O. Daugulis, J. Am. Chem. Soc, 2013, 135, 9342-9345.
12. S. Bloom, C. R. Pitts, R. Woltornist, A. Griswold, M. G. Holl and T. Lectka, Org. Lett , 2013, 15, 1722- 1724.
13. S. J. Lou, D. Q. Xu, A. B. Xia, Y. F. Wang, Y. K. Liu, X. H. Du and Z. Y. Xu, Chem. Commun., 2013, 49,
6218-6220.
14. S. J. Lou, D. Q. Xu and Z. Y. Xu, Angew. Chem., Int. Ed , 2014, 53, 10330-10335.
15. Y. D. Ye and M. S. Sanford, J. Am. Chem. Soc, 2013, 135, 4648-4651.
16. C. W. Zhang, Z. D. Li, L. Zhu, L. M. Yu, Z. T. Wang and C. Z. Li, J. Am. Chem. Soc, 2013, 135, 14082- 14085.
17. S. Bloom, C. R. Pitts, D. C. Miller, N. Haselton, M. G. Holl, E. Urheim and T. Lectka, Angew. Chem., Int.
Ed, 2012, 51, 10580-10583.
18. K. L. Hull, W. Q. Anani and M. S. Sanford, J. Am. Chem. Soc, 2006, 128, 7134-7135.
19. X. Wang, T.-S. Mei and J.-Q. Yu, J. Am. Chem. Soc, 2009, 131, 7520-7521.
20. K. S. L. Chan, M. Wasa, X. Wang and J.-Q. Yu, Angew. Chem., Int. Ed , 2011, 50, 9081-9084.
21. T. Furuya, A. E. Strom and T. Ritter, J. Am. Chem. Soc, 2009, 131, 1662-1663.
22. T. Furuya and T. Ritter, Org. Lett , 2009, 11, 2860-2863.
23. P. Tang and T. Ritter, Tetrahedron, 2011, 67, 4449-4454.
24. M. I. Bruce and R. C. Wallis, Aus. J. Chem. , 1979, 32, 1471-1485.
25. M. I. Bruce, G. A. Koutsantonis, M. J. Liddell and B. K. Nicholson, J. Organometal. Chem., 1987, 320,
217-227.
26. R. M. Bullock, J. Chem. Soc, Chem. Commun., 1989, 165-167.
27. M. Bassetti, V. Cadierno, J. Gimeno and C. Pasquini, Organometallics, 2008, 27, 5009-5016.
28. Y. Mutoh, K. Imai, Y. Kimura, Y. Ikeda and Y. Ishii, Organometallics, 2010, 30, 204-207.
29. K. Onitsuka, M. Nishii, Y. Matsushima and S. Takahashi, Organometallics, 2004, 23, 5630-5632.
30. M. E. Slaney, D. J. Anderson, M. J. Ferguson, R. McDonald and M. Cowie, J. Am. Chem. Soc, 2010, 132,
16544-16558.
31. D. G. Johnson, J. M. Lynam, N. S. Mistry, J. M. Slattery, R. J. Thatcher and A. C. Whitwood, J. Am. Chem.
Soc, 2013, 135, 2222-2234.
32. M. J. Cowley, J. M. Lynam and J. M. Slattery, Dalton Trans, 2008, 4552-4554.
33. L. Dahlenburg, A. Weiss and M. Moll, J. Organometal. Chem, 1997, 535, 195-200.
34. T M. Blackmor, M. I. Bruce and F. G. A. Stone, J. Chem. Soc. A, 1971, 2376-2382.
0442P.WO.Spec(3)

Claims

Claims
1. A method of fluorination of an alkenyl, alkynyl, aryl or isonitrile compound which comprises reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer-sphere electrophilic fluorinating (OSEF) agent.
2. A method according to claim 1 which comprises the formation of one or more bonds selected from a C-F bond, a C-S-F bond and a C-S-CF3 bond.
3. A method according to claims 1 or 2 which comprises the formation of one or more C-F bonds.
4. A method according to any one of claims 1 to 3 which comprises the introduction of a single fluorine atom.
5. A method according to any one of claims 1 to 3 which involves the incorporation of multiple fluorine atoms.
6. A method according to claims 1 or 2 which comprises the formation of one or more C-CF3 bonds.
7. A method according to claims 1, 2 or 6 which comprises the introduction of a single trifluoromethyl (-CF3) group.
8. A method according to claims 1, 2 or 6 which involves the incorporation of multiple trifluoromethyl (-CF3) groups.
9. A method according to claims 1 or 2 which comprises the formation of one or more C-S-F bonds.
10. A method according to claims 2 or 9 wherein the S represents S02.
11. A method according to claim 9 which comprises the formation of a single C-S-F bond.
12. A method according to claim 9 which comprises the formation of multiple C-S-F bonds.
13. A method according to claims 1 or 2 which comprises the formation of one or more C-S-CFs bonds.
14. A method according to claim 13 wherein the S represents S02.
15. A method according to claim 13 which comprises the formation of a single C-S-CF3 bonds.
16. A method according to claim 13 which comprises the formation of multiple C-S-CF3 bonds.
17. A method according to any one of the preceding claims wherein the bond formation is facilitated by metal-ligand in which the metal is capable of back donation or formal metal oxidation from the Mn to the M(n+2) oxidation state.
18. A method according to any one of the preceding claims wherein comprising direct outer-sphere electrophilic fluorination of a ligand bound to a metal centre.
19. A method according to any one of the preceding claims wherein the metal comprises iron or one or more Platinum Group Metals.
20. A method according to any one of the preceding claims wherein the metal is selected from the group comprising one or more of iron, iridium, osmium, palladium, platinum, rhodium and ruthenium.
21. A method according to any one of the preceding claims wherein the metal comprises ruthenium.
22. A method according to any one of the preceding claims wherein the metal is in the form of a metal complex comprising a metal and a "capping ligand" and one or more monovalent or neutral ligands.
23. A method according to claim 22 wherein the "capping ligand" is an aryl group.
24. A method according to claims 22 or 23 wherein the "capping ligand" is selected from the group consisting of C5H5, C5Me5, C6¾, C7H7, tris(pyrazolyl).
25. A method according to claim 22 wherein the one or more monovalent or neutral ligands is selected from the group consisting of -CO, -C02, phosphine, halide, -S(0)R4R5, in which R4 and R5, which may be the same or different, are each hydrogen, alkyl CI to 20 or aryl.
26. A method according to claims 22 or 25 wherein the one or more monovalent or neutral ligand comprises chloride.
27. A method according to claims 22 or 25 wherein the one or more monovalent or
1 2 3 1 2 3
neutral ligand comprises -PH3 and -PR R R , in which R , R and R , which may be the same or different, are each alkyl CI to 20 or aryl.
28. A method according to any one of the preceding claims wherein the amount of the metal or metal complex is stoichiometric.
29. A method according to any one of claims 1 to 27 wherein the amount of the metal or metal complex is catalytic.
30. A method according to any one of the preceding claims wherein the outer-sphere electrophilic fluorinating (OSEF) agent is in the form of an organo metallic complex with a latent source of "F+", "CF3 +", "SCF3 +", or "S02CF3 +".
31. A method according to any one of the preceding claims wherein the outer-sphere electrophilic fluorinating (OSEF) agent is in the form of an organo metallic complex with a latent source of "F+" or "CF3 +".
32. A method according to claim 30 or 31 wherein the latent source of "F+" comprises an N-F fluorinating agent.
33. A method according to claims 30 to 32 wherein the latent source of "F+" comprises one or more of N-fluorosulfon/w/des, such as N-fluorobenzenesulfonimide (NFSI) and N- fluoro-o-benzenedisulfonimide ( FOBS); N- fluoropyridinium salts, including N- fluoropyridinium tetrafluoroborate ([C5H5 F][BF4]), tri-alkyl pyridinium tetrafluoroborates, such as, l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate ([2,4,6-Me3C5H2 F][BF4]), 1- fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate, 2,6-dichloro- 1 - fluoropyridimnium trifluoromethanesulfonate or l-fluoro 2,6-dichloropyridinium tetrafluoroborate; l,4-diazabicyclo[2.2.2]octane (DABCO) bis(ammonium) ions, such as 1- chloromethyl-4-fluoro- 1 ,4-diazoniabicyclo [2.2.2] octane bis(tetrafluoroborate (Selectfluor®); and N-fluoro-N'-(chloromethyl)triethylenediamine bis(tetrafluoroborate).
34. A method according to any one of claims 30 to 33 wherein the organic compound is a strongly nucleophilic substrate and the latent source of "F+" comprises one or more of N- fluorosulfon/w/des, such as N-fluorobenzenesulfonimide (NFSI) and N-fluoro-o- benzenedisulfonimide (NFOBS); N- fluoropyridinium salts, including tri-alkyl pyridinium tetrafluoroborates, such as, l-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate ([2,4,6- Me3C5H2NF][BF ]), l-fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate, 2,6- dichloro- 1 -fluoropyridimnium trifluoromethanesulfonate or l-fluoro 2,6-dichloropyridinium tetrafluoroborate; l,4-diazabicyclo[2.2.2]octane (DABCO) bis(ammonium) ions, such as 1- chloromethyl-4-fluoro- 1 ,4-diazoniabicyclo [2.2.2] octane bis(tetrafluoroborate (Selectfluor®); and N-fluoro-N'-(chloromethyl)triethylenediamine bis(tetrafluoroborate).
35. A method according to claims 30 or 31 wherein the latent source of "CF3 +" comprises one or more of 5-(trifluoromethyl)dibenzothiophenium tetrafluoroborate, 5- (trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate and 3, 3 -dimethyl- 1- (trifluoromethyl)- 1 ,2-benziodoxole.
36. A method according to claims 30, 31 or 35 wherein the latent source of "CF3 +" comprises 5-(trifluoromethyl)dibenzothiophenium tetrafluoroborate.
37. A method according to claim 46 wherein the latent source of "SCF3 +" comprises one or more of trifluoromethanesulfenylchloride, 2,2,2-trifluoro-,OS'-(trifluoromethyl) ester ethane(thioperoxoic) acid, 1, 1, 1 -trifluoro-N-methyl-N-phenyl-methanesulfenylamide, £/s(trifluoromethyl)disulfide, 1 , 3 -dihydro-3 , 3 -dimethyl- 1 - [(trifluoromethyl)thio] - 1 ,2- benziodoxole and 2-[(trifluoromethyl)thio]-lH-isoindole-l,3(2H)-dione.
38. A method according to claim 46 wherein the latent source of "S02CF3 +" comprises one or more of 1, 1, 1-trifluoro-, 1, 1 '-anhydride, 1, 1, 1-trifluoro-N-phenyl-N- [ (trifluoromethyl) sulfonyl] -methanesulfonic acid, trifluoro-methanesulfonylchloride.
39. A method according to any one of the preceding claims which comprises fluorinating an alkynyl compound.
40. A method according to any one of claims 1 to 36 which comprises fluorinating an alkenyl compound.
41. A method according to any one of claims 1 to 36 which comprises fluorinating an aryl compound.
42. A method according to any one of claims 1 to 36 which comprises fluorinating an isonitrile compound.
43. A method according to according to claim 39 which comprises fluorinating an alkynyl compound:
Figure imgf000110_0001
wherein [M] is metal-based complex, such as, [M^XI^XL2)] (M = Mn, Re, Fe, Ru, Os, Rh, Ir; L is a facially capping ligand such as C5H5, C5Me5, 06Η6, C7H7, Tp, etc., L1 = CO, phosphine, halide, L2 = same ligand set as L1 may be the same or different in each case); and R, is H, a carbon containing organic group, i.e. linear branched or cyclic groups, or a heteroatom (such as N, O, S etc.) with associated functional groups.
44. A method according to according to claims 39 or 43 which comprises:
Figure imgf000111_0001
wherein R is an aryl group or hydrogen.
45. A method according to according to claim 40 which comprises fluorinating an alkenyl compound:
Figure imgf000111_0002
wherein [M] is metal-based complex, such as, [M^XI^XL2)] (M = Mn, Re, Fe, Ru, Os, Rh, Ir; L is a facially capping ligand such as C5H5, C5Me5, 06Η6, C7H7, Tp, etc., L1 = CO, phosphine, halide, L2 = same ligand set as L1 may be the same or different in each case); and R, is H, a carbon containing organic group, i.e. linear, branched or cyclic groups, or a heteroatom (such as N, O, S etc.) with associated functional groups.
46. A method according to according to claims 40 or 45 wherein the substrate is selected from the group consisting of:
Figure imgf000112_0001
A method according to according to claim 41 which comprises one of the processes:
Figure imgf000112_0002
48. A compound comprising a fluorinated alkenyl, aryl or isonitrile compound prepared by reacting an alkenyl, alkynyl, aryl or isonitrile compound with a metal-mediated outer- sphere electrophilic fluorinating (OSEF) agent according to any one of the preceding claims.
49. A compound according to claim 48 wherein the compound is a fluorinated alkenyl compound.
50. A compound according to claim 49 wherein the compound is a fluorinated aryl compound.
51. A compound according to claim 48 wherein the compound is a fluorinated isonitrile compound.
I l l
52. A method or compound as hereinbefore described with reference to the accompanying description and figures.
0442P.WO.Spec(3)
PCT/GB2015/053732 2014-12-04 2015-12-04 Formation of bonds by outer-sphere oxidative electrophilic fluorination WO2016087879A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1421598.2 2014-12-04
GBGB1421598.2A GB201421598D0 (en) 2014-12-04 2014-12-04 Formation of C-F bonds by outer sphere oxidative electrophilic fluorination

Publications (1)

Publication Number Publication Date
WO2016087879A1 true WO2016087879A1 (en) 2016-06-09

Family

ID=52425464

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2015/053732 WO2016087879A1 (en) 2014-12-04 2015-12-04 Formation of bonds by outer-sphere oxidative electrophilic fluorination

Country Status (2)

Country Link
GB (1) GB201421598D0 (en)
WO (1) WO2016087879A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109428038A (en) * 2017-08-31 2019-03-05 比亚迪股份有限公司 A kind of battery diaphragm and preparation method thereof and lithium ion battery
DE102018211606A1 (en) 2018-07-12 2020-01-16 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Dibenzothiophene salt as an alkynylation and cyanation agent

Non-Patent Citations (39)

* Cited by examiner, † Cited by third party
Title
A. R. MAZZOTTI; M. G. CAMPBELL; P. P. TANG; J. M. MURPHY; T. RITTER, J. AM. CHEM. SOC, vol. 135, 2013, pages 14012 - 14015
C. W. ZHANG; Z. D. LI; L. ZHU; L. M. YU; Z. T. WANG; C. Z. LI, J. AM. CHEM. SOC, vol. 135, 2013, pages 14082 - 14085
D. G. JOHNSON; J. M. LYNAM; N. S. MISTRY; J. M. SLATTERY; R. J. THATCHER; A. C. WHITWOOD, J. AM. CHEM. SOC., vol. 135, 2013, pages 2222 - 2234
D. TOUCHARD; P. HAQUETTE; N. PIRIO; L. TOUPET; P. H. DIXNEUF, ORGANOMETALLICS, vol. 12, 1993, pages 3132 - 3139
H. DANG; M. MAILIG; G. LALIC, ANGEW. CHEM., INT. ED., vol. 53, 2014, pages 6473 - 6476
H. G. LEE; P. J. MILNER; S. L. BUCHWALD, J. AM. CHEM. SOC, vol. 136, 2014, pages 3792 - 3795
J. WU, TETRAHEDRON LETT., vol. 55, 2014, pages 4289 - 4294
K. L. HULL; W. Q. ANANI; M. S. SANFORD, J. AM. CHEM. SOC, vol. 128, 2006, pages 7134 - 7135
K. ONITSUKA; M. NISHII; Y. MATSUSHIMA; S. TAKAHASHI, ORGANOMETALLICS, vol. 23, 2004, pages 5630 - 5632
K. S. L. CHAN; M. WASA; X. WANG; J.-Q. YU, ANGEW. CHEM., INT. ED., vol. 50, 2011, pages 9081 - 9084
L. DAHLENBURG; A. WEISS; M. MOLL, J. ORGANOMETAL. CHEM, vol. 535, 1997, pages 195 - 200
M. BASSETTI; V. CADIEMO; J. GIMENO; C. PASQUINI, ORGANOMETALLICS, vol. 27, 2008, pages 5009 - 5016
M. E. SLANEY; D. J. ANDERSON; M. J. FERGUSON; R. MCDONALD; M. COWIE, J. AM. CHEM. SOC, vol. 132, 2010, pages 16544 - 16558
M. G. BRAUN; A. G. DOYLE, J. AM. CHEM. SOC, vol. 135, 2013, pages 12990 - 12993
M. G. BRAUN; M. H. KATCHER; A. G. DOYLE, CHEM. SCI., vol. 4, 2013, pages 1216 - 1220
M. I. BRUCE; A. G. SWINCER, AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 33, 1980, pages 1471 - 1483
M. I. BRUCE; G. A. KOUTSANTONIS; M. J. LIDDELL; B. K. NICHOLSON, J. ORGANOMETAL. CHEM., vol. 320, 1987, pages 217 - 227
M. I. BRUCE; M. A. FOX; P. J. LOW; B. K. NICHOLSON; C. R. PARKER; W. C. PATALINGHUG; B. W. SKELTON; A. H. WHITE, ORGANOMETALLICS, vol. 31, 2012, pages 2639 - 2657
M. I. BRUCE; R. C. WALLIS, AUS. J. CHEM., vol. 32, 1979, pages 1471 - 1485
M. J. COWLEY; J. M. LYNAM; J. M. SLATTERY, DALTON TRANS, 2008, pages 4552 - 4554
N. ICHIISHI; A. J. CANTY; B. F. YATES; M. S. SANFORD, ORG. LETT., vol. 15, 2013, pages 5134 - 5137
P. TANG; T. RITTER, TETRAHEDRON, vol. 67, 2011, pages 4449 - 4454
R. M. BULLOCK, J. CHEM. SOC., CHEM. COMMUN., 1989, pages 165 - 167
S. BLOOM; C. R. PITTS; D. C. MILLER; N. HASELTON; M. G. HOLL; E. URHEIM; T. LECTKA, ANGEW. CHEM., INT. ED., vol. 51, 2012, pages 10580 - 10583
S. BLOOM; C. R. PITTS; R. WOLTORNIST; A. GRISWOLD; M. G. HOLL; T. LECTKA, ORG. LETT., vol. 15, 2013, pages 1722 - 1724
S. J. LOU; D. Q. XU; A. B. XIA; Y. F. WANG; Y. K. LIU; X. H. DU; Z. Y. XU, CHEM. COMMUN., vol. 49, 2013, pages 6218 - 6220
S. J. LOU; D. Q. XU; Z. Y. XU, ANGEW. CHEM., INT. ED., vol. 53, 2014, pages 10330 - 10335
T M. BLACKMOR; M. I. BRUCE; F. G. A. STONE, J. CHEM. SOC. A, 1971, pages 2376 - 2382
T. FURUYA; A. E. STROM; T. RITTER, J. AM. CHEM. SOC, vol. 131, 2009, pages 1662 - 1663
T. FURUYA; T. RITTER, ORG. LETT., vol. 11, 2009, pages 2860 - 2863
T. LIANG; C. N. NEUMANN; T. RITTER, ANGEW. CHEM., INT. ED., vol. 52, 2013, pages 8214 - 8264
T. LIANG; C. N. NEUMANN; T. RITTER, ANGEW. CHEM., INT. ED., vol. 52, 2013, pages 8214 - 8264, XP055182650 *
T. TRUONG; K. KLIMOVICA; O. DAUGULIS, J. AM. CHEM. SOC, vol. 135, 2013, pages 9342 - 9345
W. LIU; J. T. GROVES, ANGEW. CHEM., INT. ED.,, vol. 52, 2013, pages 6024 - 6027
X. WANG; T-S. MEI; J.-Q. YU, J AM. CHEM. SOC, vol. 131, 2009, pages 7520 - 7521
X. Y. HUANG; W. LIU; H. REN; R. NEELAMEGAM; J. M. HOOKER; J. T. GROVES, J. AM. CHEM. SOC, vol. 136, 2014, pages 6842 - 6845
XIAOYU YANG ET AL: "Advances in Catalytic Enantioselective Fluorination, Mono-, Di-, and Trifluoromethylation, and Trifluoromethylthiolation Reactions", CHEMICAL REVIEWS, vol. 115, no. 2, 22 October 2014 (2014-10-22), US, pages 826 - 870, XP055258702, ISSN: 0009-2665, DOI: 10.1021/cr500277b *
Y. D. YE; M. S. SANFORD, J. AM. CHEM. SOC, vol. 135, 2013, pages 4648 - 4651
Y. MUTOH; K. IMAI; Y. KIMURA; Y. IKEDA; Y. ISHII, ORGANOMETALLICS, vol. 30, 2010, pages 204 - 207

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109428038A (en) * 2017-08-31 2019-03-05 比亚迪股份有限公司 A kind of battery diaphragm and preparation method thereof and lithium ion battery
CN109428038B (en) * 2017-08-31 2020-08-25 比亚迪股份有限公司 Battery diaphragm, preparation method thereof and lithium ion battery
DE102018211606A1 (en) 2018-07-12 2020-01-16 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Dibenzothiophene salt as an alkynylation and cyanation agent
WO2020011935A1 (en) 2018-07-12 2020-01-16 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Dibenzothiopene salt as alkinylating and cyanating agent
US11447462B2 (en) 2018-07-12 2022-09-20 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Dibenzothiophene salt as alkynylating and cyanating agent

Also Published As

Publication number Publication date
GB201421598D0 (en) 2015-01-21

Similar Documents

Publication Publication Date Title
Segawa et al. Chemistry of boryllithium: synthesis, structure, and reactivity
Fedushkin et al. Digallane with redox-active diimine ligand: Dualism of electron-transfer reactions
Fliedel et al. Thioether-Functionalized N-Heterocyclic Carbenes: Mono-and Bis-(S, C NHC) Palladium Complexes, Catalytic C− C Coupling, and Characterization of a Unique Ag4I4 (S, C NHC) 2 Planar Cluster
Carpenter et al. Comparative measure of the electronic influence of highly substituted aryl isocyanides
Arrowsmith et al. Mononuclear three-coordinate magnesium complexes of a highly sterically encumbered β-diketiminate ligand
Nogai et al. Dichlorogallane (HGaCl2) 2: Its molecular structure and synthetic potential
Saleh et al. Chlorination of 1-Carba-closo-dodecaborate and 1-Ammonio-closo-dodecaborate Anions
Ramirez-Rave et al. Synthesis and characterization of new Pd (II) non-symmetrical pincer complexes derived from thioether functionalized iminophosphoranes. Evaluation of their catalytic activity in the Suzuki–Miyaura couplings
Lebedev et al. Coordination Chemistry of [E (Idipp)] 2+ Ligands (E= Ge, Sn): Metal Germylidyne [Cp*(CO) 2W Ge (Idipp)]+ and Metallotetrylene [Cp*(CO) 3W–E (Idipp)]+ Cations
Maleckis et al. Facial tridentate ligands for stabilizing palladium (IV) complexes
Hu et al. Constructing a catalytic cycle for C–F to C–X (X= O, S, N) bond transformation based on gold-mediated ligand nucleophilic attack
Gianopoulos et al. Mono-and bimetallic aluminum alkyl, aryl, and hydride complexes of a bulky dipyrromethene ligand
Tate et al. Stable mono-and dinuclear organosilver complexes
Machura et al. Rhenium (V) oxocomplexes [ReOX (N–O) 2] and [ReOL (N–O) 2]+—Synthesis, structure, spectroscopy and catalytic properties
Joksch et al. Synthesis and characterisation of ring-substituted POCOP halide complexes of group 10 metals
Hill et al. Synthesis of a stable methylidyne complex
Puerta-Oteo et al. Zwitterionic rhodium and iridium complexes based on a carboxylate bridge-functionalized bis-N-heterocyclic carbene ligand: Synthesis, structure, dynamic behavior, and reactivity
Lin et al. Bis-and tris-phosphinostannane gold complexes featuring Au→ Sn dative interactions: Synthesis, structures, and DFT calculations
Calvet et al. Kinetico-Mechanistic Insight into the Platinum-Mediated C− C Coupling of Fluorinated Arenes
Delaney et al. Synthesis of an expanded pincer ligand and its bimetallic coinage metal complexes
WO2016087879A1 (en) Formation of bonds by outer-sphere oxidative electrophilic fluorination
Roemer et al. Bulky-Alkyl-Substituted Bis (trifluorovinyl) ferrocenes: Redox-Autocatalytic Formation of Fluorinated Ferrocenophanes
Sharp-Bucknall et al. Reactivity Studies of Cationic Au (III) Difluorides Supported by N Ligands
Ciganda et al. Reactions of Hydridoirida-β-diketones with Amines or with 2-Aminopyridines: Formation of Hydridoirida-β-ketoimines, PCN Terdentate Ligands, and Acyl Decarbonylation
Montoya et al. Synthesis, spectroscopic properties and structural characterisation of Pd (II) and Pt (II) complexes with 1, 3, 5-pyrazole derived ligands. Rotation around the metal–N bond

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15828751

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15828751

Country of ref document: EP

Kind code of ref document: A1